<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Implement Sci</journal-id><journal-id journal-id-type="iso-abbrev">Implement Sci</journal-id><journal-title-group><journal-title>Implementation Science : IS</journal-title></journal-title-group><issn pub-type="epub">1748-5908</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25267385</article-id><article-id pub-id-type="pmc">4189548</article-id><article-id pub-id-type="publisher-id">132</article-id><article-id pub-id-type="doi">10.1186/s13012-014-0132-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Protocol: Adaptive Implementation of Effective Programs Trial (ADEPT): cluster randomized SMART trial comparing a standard versus enhanced implementation strategy to improve outcomes of a mood disorders program</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" deceased="no" equal-contrib="no"><name><surname>Kilbourne</surname><given-names>Amy M</given-names></name><address><email>amykilbo@umich.edu</email></address><xref ref-type="aff" rid="Aff1"></xref><xref ref-type="aff" rid="Aff2"></xref></contrib><contrib contrib-type="author" deceased="no" equal-contrib="no"><name><surname>Almirall</surname><given-names>Daniel</given-names></name><address><email>dalmiral@umich.edu</email></address><xref ref-type="aff" rid="Aff3"></xref></contrib><contrib contrib-type="author" deceased="no" equal-contrib="no"><name><surname>Eisenberg</surname><given-names>Daniel</given-names></name><address><email>daneis@umich.edu</email></address><xref ref-type="aff" rid="Aff4"></xref></contrib><contrib contrib-type="author" deceased="no" equal-contrib="no"><name><surname>Waxmonsky</surname><given-names>Jeanette</given-names></name><address><email>Jeanette.waxmonsky@coaccess.com</email></address><xref ref-type="aff" rid="Aff5"></xref><xref ref-type="aff" rid="Aff6"></xref></contrib><contrib contrib-type="author" deceased="no" equal-contrib="no"><name><surname>Goodrich</surname><given-names>David E</given-names></name><address><email>David.goodrich2@va.gov</email></address><xref ref-type="aff" rid="Aff1"></xref><xref ref-type="aff" rid="Aff2"></xref></contrib><contrib contrib-type="author" deceased="no" equal-contrib="no"><name><surname>Fortney</surname><given-names>John C</given-names></name><address><email>John.fortney@va.gov</email></address><xref ref-type="aff" rid="Aff7"></xref></contrib><contrib contrib-type="author" deceased="no" equal-contrib="no"><name><surname>Kirchner</surname><given-names>JoAnn E</given-names></name><address><email>JoAnn.Kirchner@va.gov</email></address><xref ref-type="aff" rid="Aff8"></xref><xref ref-type="aff" rid="Aff9"></xref></contrib><contrib contrib-type="author" deceased="no" equal-contrib="no"><name><surname>Solberg</surname><given-names>Leif I</given-names></name><address><email>Leif.iI.sSolberg@hHealthpPartners.com</email></address><xref ref-type="aff" rid="Aff10"></xref></contrib><contrib contrib-type="author" deceased="no" equal-contrib="no"><name><surname>Main</surname><given-names>Deborah</given-names></name><address><email>Debbi.Main@UCDenver.edu</email></address><xref ref-type="aff" rid="Aff11"></xref></contrib><contrib contrib-type="author" deceased="no" equal-contrib="no"><name><surname>Bauer</surname><given-names>Mark S</given-names></name><address><email>Mark.Bauer@va.gov</email></address><xref ref-type="aff" rid="Aff12"></xref></contrib><contrib contrib-type="author" deceased="no" equal-contrib="no"><name><surname>Kyle</surname><given-names>Julia</given-names></name><address><email>Clogston@umich.edu</email></address><xref ref-type="aff" rid="Aff1"></xref><xref ref-type="aff" rid="Aff2"></xref></contrib><contrib contrib-type="author" deceased="no" equal-contrib="no"><name><surname>Murphy</surname><given-names>Susan A</given-names></name><address><email>samurphy@umich.edu</email></address><xref ref-type="aff" rid="Aff3"></xref><xref ref-type="aff" rid="Aff3"></xref></contrib><contrib contrib-type="author" deceased="no" equal-contrib="no"><name><surname>Nord</surname><given-names>Kristina M</given-names></name><address><email>kmnord@umich.edu</email></address><xref ref-type="aff" rid="Aff1"></xref><xref ref-type="aff" rid="Aff2"></xref></contrib><contrib contrib-type="author" deceased="no" equal-contrib="no"><name><surname>Thomas</surname><given-names>Marshall R</given-names></name><address><email>Marshall.Thomas@coaccess.com</email></address><xref ref-type="aff" rid="Aff5"></xref><xref ref-type="aff" rid="Aff6"></xref></contrib><aff id="Aff1"><label></label>VA Center for Clinical Management Research, VA Ann Arbor Healthcare System, 2215 Fuller Rd, Mailstop 152, Ann Arbor, 48105 MI USA </aff><aff id="Aff2"><label></label>Department of Psychiatry, North Campus Research Complex, University of Michigan Medical School, 2800 Plymouth Rd, Bldg 16, Ann Arbor, 48109-2800 MI USA </aff><aff id="Aff3"><label></label>Institute for Social Research, University of Michigan, 426 Thompson Street, Ann Arbor, 48104-2321 MI USA </aff><aff id="Aff4"><label></label>Department of Health Management and Policy, School of Public Health, University of Michigan, 1415 Washington Heights, Ann Arbor, 48109-2029 MI USA </aff><aff id="Aff5"><label></label>Colorado Access, 10065 E. Harvard Ave, Suite 600, Denver, 80231 CO USA </aff><aff id="Aff6"><label></label>Department of Psychiatry, University of Colorado School of Medicine, 13199 East Montview Blvd, Mailstop F550, Suite 330, Aurora, 80045 CO USA </aff><aff id="Aff7"><label></label>Seattle HSR&amp;D Center of Innovation for Veteran-Centered and Value-Driven Care, VA Puget Sound Health Care System, 1660 S. Columbian Way, S-152, Seattle, 98108 WA USA </aff><aff id="Aff8"><label></label>VA Mental Health Quality Enhancement Research Initiative (MH QUERI), North Little Rock, 27114 AR USA </aff><aff id="Aff9"><label></label>Department of Psychiatry, College of Medicine, University of Arkansas for Medical Sciences, 4301 W. Markham, Little Rock, 72205 AR USA </aff><aff id="Aff10"><label></label>HealthPartners Institute for Education and Research, 3311 E. Old Shakopee Road, Bloomington, 55425 MN USA </aff><aff id="Aff11"><label></label>Department of Health and Behavioral Sciences, University of Colorado Denver, Denver, 80217 CO USA </aff><aff id="Aff12"><label></label>VA Center for Healthcare Organization and Implementation Research, VA Boston Healthcare System, Bldg 9, Jamaica Plain Campus, 150 South Huntington Ave (152 M), Boston, 02130 MA USA </aff></contrib-group><pub-date pub-type="epub"><day>30</day><month>9</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>30</day><month>9</month><year>2014</year></pub-date><pub-date pub-type="collection"><year>2014</year></pub-date><volume>9</volume><elocation-id>132</elocation-id><history><date date-type="received"><day>8</day><month>8</month><year>2014</year></date><date date-type="accepted"><day>19</day><month>9</month><year>2014</year></date></history><permissions><copyright-statement>© Kilbourne et al.; licensee BioMed Central Ltd. 2014</copyright-statement><license license-type="open-access"><license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title><offsets xml_i="8290" xml_f="8300" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="8311" xml_f="8918" txt_i="22" txt_f="629">Despite the availability of psychosocial evidence-based practices (EBPs), treatment and outcomes for persons with mental disorders remain suboptimal. Replicating Effective Programs (REP), an effective implementation strategy, still resulted in less than half of sites using an EBP. The primary aim of this cluster randomized trial is to determine, among sites not initially responding to REP, the effect of adaptive implementation strategies that begin with an External Facilitator (EF) or with an External Facilitator plus an Internal Facilitator (IF) on improved EBP use and patient outcomes in 12 months.</offsets></p></sec><sec><title><offsets xml_i="8940" xml_f="8954" txt_i="631" txt_f="645">Methods/Design</offsets></title><p><offsets xml_i="8965" xml_f="9219" txt_i="646" txt_f="900">This study employs a sequential multiple assignment randomized trial (SMART) design to build an adaptive implementation strategy. The EBP to be implemented is life goals (LG) for patients with mood disorders across 80 community-based outpatient clinics (</offsets><italic><offsets xml_i="9227" xml_f="9228" txt_i="900" txt_f="901">N</offsets></italic><offsets xml_i="9237" xml_f="9948" txt_i="901" txt_f="1609"> N = 1,600 patients) from different U.S. regions. Sites not initially responding to REP (defined as &lt;50% patients receiving ≥3 EBP sessions) will be randomized to receive additional support from an EF or both EF/IF. Additionally, sites randomized to EF and still not responsive will be randomized to continue with EF alone or to receive EF/IF. The EF provides technical expertise in adapting LG in routine practice, whereas the on-site IF has direct reporting relationships to site leadership to support LG use in routine practice. The primary outcome is mental health-related quality of life; secondary outcomes include receipt of LG sessions, mood symptoms, implementation costs, and organizational change.</offsets></p></sec><sec><title><offsets xml_i="9970" xml_f="9980" txt_i="1611" txt_f="1621">Discussion</offsets></title><p><offsets xml_i="9991" xml_f="10297" txt_i="1622" txt_f="1928">This study design will determine whether an off-site EF alone versus the addition of an on-site IF improves EBP uptake and patient outcomes among sites that do not respond initially to REP. It will also examine the value of delaying the provision of EF/IF for sites that continue to not respond despite EF.</offsets></p></sec><sec><title><offsets xml_i="10319" xml_f="10337" txt_i="1930" txt_f="1948">Trial registration</offsets></title><p><offsets xml_i="10348" xml_f="10379" txt_i="1949" txt_f="1980">ClinicalTrials.gov identifier: </offsets><ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT02151331?term=NCT02151331&amp;rank=1"><offsets xml_i="10498" xml_f="10509" txt_i="1980" txt_f="1991">NCT02151331</offsets></ext-link></p></sec><sec><title><offsets xml_i="10542" xml_f="10575" txt_i="1993" txt_f="2026">Electronic supplementary material</offsets></title><p><offsets xml_i="10586" xml_f="10725" txt_i="2027" txt_f="2166">The online version of this article (doi:10.1186/s13012-014-0132-x) contains supplementary material, which is available to authorized users.</offsets></p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Adaptive intervention</kwd><kwd>Depression</kwd><kwd>Health behavior change</kwd><kwd>Care management</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© The Author(s) 2014</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title><offsets xml_i="11128" xml_f="11138" txt_i="2175" txt_f="2185">Background</offsets></title><p><offsets xml_i="11149" xml_f="11243" txt_i="2186" txt_f="2280">It can take years to translate evidence-based practices (EBPs) into community-based settings [</offsets><xref ref-type="bibr" rid="CR1"><offsets xml_i="11275" xml_f="11276" txt_i="2280" txt_f="2281">1</offsets></xref><offsets xml_i="11283" xml_f="11625" txt_i="2281" txt_f="2623">]. This research-to-practice gap is especially pronounced for psychosocial EBPs for mood disorders (depression, bipolar disorders), which represent the top ten causes of disability according to the World Health Organization. Mood disorders are associated with significant functional impairment, high medical costs, and preventable mortality [</offsets><xref ref-type="bibr" rid="CR2"><offsets xml_i="11657" xml_f="11658" txt_i="2623" txt_f="2624">2</offsets></xref><offsets xml_i="11665" xml_f="11668" txt_i="2624" txt_f="2627">],[</offsets><xref ref-type="bibr" rid="CR3"><offsets xml_i="11700" xml_f="11701" txt_i="2627" txt_f="2628">3</offsets></xref><offsets xml_i="11708" xml_f="11854" txt_i="2628" txt_f="2774">]. For many patients, pharmacotherapy is not enough to improve outcomes, with psychosocial treatments in addition to pharmacotherapy recommended [</offsets><xref ref-type="bibr" rid="CR4"><offsets xml_i="11886" xml_f="11887" txt_i="2774" txt_f="2775">4</offsets></xref><offsets xml_i="11894" xml_f="11897" txt_i="2775" txt_f="2778">]-[</offsets><xref ref-type="bibr" rid="CR7"><offsets xml_i="11929" xml_f="11930" txt_i="2778" txt_f="2779">7</offsets></xref><offsets xml_i="11937" xml_f="11939" txt_i="2779" txt_f="2781">].</offsets></p><p><offsets xml_i="11946" xml_f="11993" txt_i="2782" txt_f="2829">Despite the availability of psychosocial EBPs [</offsets><xref ref-type="bibr" rid="CR1"><offsets xml_i="12025" xml_f="12026" txt_i="2829" txt_f="2830">1</offsets></xref><offsets xml_i="12033" xml_f="12036" txt_i="2830" txt_f="2833">],[</offsets><xref ref-type="bibr" rid="CR4"><offsets xml_i="12068" xml_f="12069" txt_i="2833" txt_f="2834">4</offsets></xref><offsets xml_i="12076" xml_f="12079" txt_i="2834" txt_f="2837">]-[</offsets><xref ref-type="bibr" rid="CR8"><offsets xml_i="12111" xml_f="12112" txt_i="2837" txt_f="2838">8</offsets></xref><offsets xml_i="12119" xml_f="12213" txt_i="2838" txt_f="2932">] for mood disorders, they rarely get implemented and sustained in community-based practices [</offsets><xref ref-type="bibr" rid="CR9"><offsets xml_i="12245" xml_f="12246" txt_i="2932" txt_f="2933">9</offsets></xref><offsets xml_i="12253" xml_f="12256" txt_i="2933" txt_f="2936">]-[</offsets><xref ref-type="bibr" rid="CR11"><offsets xml_i="12289" xml_f="12291" txt_i="2936" txt_f="2938">11</offsets></xref><offsets xml_i="12298" xml_f="12527" txt_i="2938" txt_f="3167">]. This is primarily due to a lack of available strategies to help providers embed the EBP into routine clinical workflows, and garner support from clinical and administrative leadership on the EBP’s added value to the practice [</offsets><xref ref-type="bibr" rid="CR8"><offsets xml_i="12559" xml_f="12560" txt_i="3167" txt_f="3168">8</offsets></xref><offsets xml_i="12567" xml_f="12570" txt_i="3168" txt_f="3171">],[</offsets><xref ref-type="bibr" rid="CR12"><offsets xml_i="12603" xml_f="12605" txt_i="3171" txt_f="3173">12</offsets></xref><offsets xml_i="12612" xml_f="12615" txt_i="3173" txt_f="3176">]-[</offsets><xref ref-type="bibr" rid="CR25"><offsets xml_i="12648" xml_f="12650" txt_i="3176" txt_f="3178">25</offsets></xref><offsets xml_i="12657" xml_f="12735" txt_i="3178" txt_f="3256">]. As a result, outcomes for persons with mental disorders remain suboptimal [</offsets><xref ref-type="bibr" rid="CR12"><offsets xml_i="12768" xml_f="12770" txt_i="3256" txt_f="3258">12</offsets></xref><offsets xml_i="12777" xml_f="12780" txt_i="3258" txt_f="3261">],[</offsets><xref ref-type="bibr" rid="CR26"><offsets xml_i="12813" xml_f="12815" txt_i="3261" txt_f="3263">26</offsets></xref><offsets xml_i="12822" xml_f="13025" txt_i="3263" txt_f="3466">]. New healthcare initiatives including medical home models designed to improve efficiency and value have not included specific strategies to assist local providers in implementing EBPs in routine care [</offsets><xref ref-type="bibr" rid="CR27"><offsets xml_i="13058" xml_f="13060" txt_i="3466" txt_f="3468">27</offsets></xref><offsets xml_i="13067" xml_f="13070" txt_i="3468" txt_f="3471">]-[</offsets><xref ref-type="bibr" rid="CR29"><offsets xml_i="13103" xml_f="13105" txt_i="3471" txt_f="3473">29</offsets></xref><offsets xml_i="13112" xml_f="13276" txt_i="3473" txt_f="3637">]. Moreover, up to 98% of patients with mood disorders receive care from smaller clinical practices, which may not have the tools to fully implement medical homes [</offsets><xref ref-type="bibr" rid="CR30"><offsets xml_i="13309" xml_f="13311" txt_i="3637" txt_f="3639">30</offsets></xref><offsets xml_i="13318" xml_f="13320" txt_i="3639" txt_f="3641">].</offsets></p><p><offsets xml_i="13327" xml_f="13409" txt_i="3642" txt_f="3724">For EBPs to reach these patients, effective implementation strategies are needed [</offsets><xref ref-type="bibr" rid="CR31"><offsets xml_i="13442" xml_f="13444" txt_i="3724" txt_f="3726">31</offsets></xref><offsets xml_i="13451" xml_f="13454" txt_i="3726" txt_f="3729">]-[</offsets><xref ref-type="bibr" rid="CR34"><offsets xml_i="13487" xml_f="13489" txt_i="3729" txt_f="3731">34</offsets></xref><offsets xml_i="13496" xml_f="13684" txt_i="3731" txt_f="3919">]. Implementation strategies that have been highly specified, operationalized, and previously used to implement EBPs into usual care settings include Replicating Effective Programs (REP) [</offsets><xref ref-type="bibr" rid="CR35"><offsets xml_i="13717" xml_f="13719" txt_i="3919" txt_f="3921">35</offsets></xref><offsets xml_i="13726" xml_f="13916" txt_i="3921" txt_f="4111">]. REP primarily focuses on standardization of the EBP implementation into routine care settings through toolkit development and marketing, provider training, and program assistance (Figure </offsets><xref rid="Fig1" ref-type="fig"><offsets xml_i="13948" xml_f="13949" txt_i="4111" txt_f="4112">1</offsets></xref><offsets xml_i="13956" xml_f="14027" txt_i="4112" txt_f="4183">). Used successfully to improve the uptake of brief HIV interventions [</offsets><xref ref-type="bibr" rid="CR36"><offsets xml_i="14060" xml_f="14062" txt_i="4183" txt_f="4185">36</offsets></xref><offsets xml_i="14069" xml_f="14072" txt_i="4185" txt_f="4188">]-[</offsets><xref ref-type="bibr" rid="CR39"><offsets xml_i="14105" xml_f="14107" txt_i="4188" txt_f="4190">39</offsets></xref><offsets xml_i="14114" xml_f="14331" txt_i="4190" txt_f="4407">], REP is a low-intensity intervention with minimal costs for sites. However, when applied to the implementation of a psychosocial EBP for mood disorders, REP resulted in less than half of sites implementing the EBP [</offsets><xref ref-type="bibr" rid="CR40"><offsets xml_i="14364" xml_f="14366" txt_i="4407" txt_f="4409">40</offsets></xref><offsets xml_i="14373" xml_f="14375" txt_i="4409" txt_f="4411">].</offsets><fig id="Fig1"><label><offsets xml_i="14397" xml_f="14405" txt_i="4411" txt_f="4419">Figure 1</offsets></label><caption><p><offsets xml_i="14425" xml_f="14426" txt_i="4419" txt_f="4420">
</offsets><bold><offsets xml_i="14432" xml_f="14512" txt_i="4420" txt_f="4500">Replicating Effective Programs (REP) and Internal/External Facilitation (EF/IF).</offsets></bold><offsets xml_i="14519" xml_f="14520" txt_i="4500" txt_f="4501">
</offsets></p></caption><graphic xlink:href="13012_2014_Article_132_Fig1_HTML" id="d30e619"></graphic></fig></p><p><offsets xml_i="14625" xml_f="14754" txt_i="4503" txt_f="4632">Recognizing the need for more intensive implementation strategies that leverage local provider initiative and outside expertise [</offsets><xref ref-type="bibr" rid="CR41"><offsets xml_i="14787" xml_f="14789" txt_i="4632" txt_f="4634">41</offsets></xref><offsets xml_i="14796" xml_f="14841" txt_i="4634" txt_f="4679">], REP was enhanced to include Facilitation [</offsets><xref ref-type="bibr" rid="CR40"><offsets xml_i="14874" xml_f="14876" txt_i="4679" txt_f="4681">40</offsets></xref><offsets xml_i="14883" xml_f="14886" txt_i="4681" txt_f="4684">],[</offsets><xref ref-type="bibr" rid="CR41"><offsets xml_i="14919" xml_f="14921" txt_i="4684" txt_f="4686">41</offsets></xref><offsets xml_i="14928" xml_f="15481" txt_i="4686" txt_f="5239">]. Two Facilitation roles evolved: an External Facilitator (EF), employed from outside the local site, and an Internal Facilitator (IF), employed at each of the local sites. EFs are situated at a central location and provide technical expertise and program support in implementing the EBP at the local site. In contrast, IFs have a direct reporting relationship to site leadership and have protected time to support providers in implementing EBPs by helping them align the EBP activities with the priorities of the clinic providers and local leadership.</offsets></p><p><offsets xml_i="15488" xml_f="15526" txt_i="5240" txt_f="5278">A recent randomized controlled trial [</offsets><xref ref-type="bibr" rid="CR40"><offsets xml_i="15559" xml_f="15561" txt_i="5278" txt_f="5280">40</offsets></xref><offsets xml_i="15568" xml_f="15571" txt_i="5280" txt_f="5283">],[</offsets><xref ref-type="bibr" rid="CR42"><offsets xml_i="15604" xml_f="15606" txt_i="5283" txt_f="5285">42</offsets></xref><offsets xml_i="15613" xml_f="15926" txt_i="5285" txt_f="5598">] of added an External Facilitator (REP + EF) versus REP alone found that among 88 sites not responding to REP, sites randomized to receive REP + EF compared to sites continuing with REP were more likely to adopt the EBP within 6 months (defined as percentage of patients receiving care management: 56% vs. 28%) [</offsets><xref ref-type="bibr" rid="CR42"><offsets xml_i="15959" xml_f="15961" txt_i="5598" txt_f="5600">42</offsets></xref><offsets xml_i="15968" xml_f="16347" txt_i="5600" txt_f="5979">]. This suggests that while REP + EF led to increased uptake, a more intensive, locally oriented implementation strategy (e.g., Internal Facilitation) might be needed for EBP uptake in sites that do not fully implement the EBP. In a different study, REP in combination with EF and IF (REP + EF/IF) versus standard REP alone improved adoption and fidelity to a mood disorder EBP [</offsets><xref ref-type="bibr" rid="CR43"><offsets xml_i="16380" xml_f="16382" txt_i="5979" txt_f="5981">43</offsets></xref><offsets xml_i="16389" xml_f="16392" txt_i="5981" txt_f="5984">],[</offsets><xref ref-type="bibr" rid="CR44"><offsets xml_i="16425" xml_f="16427" txt_i="5984" txt_f="5986">44</offsets></xref><offsets xml_i="16434" xml_f="16477" txt_i="5986" txt_f="6029">], underscoring the promise of REP + EF/IF.</offsets></p><p><offsets xml_i="16484" xml_f="16586" txt_i="6030" txt_f="6132">However, because IF requires additional time commitment from sites, and not all sites may need IF, an </offsets><italic><offsets xml_i="16594" xml_f="16626" txt_i="6132" txt_f="6164">adaptive implementation strategy</offsets></italic><offsets xml_i="16635" xml_f="17425" txt_i="6164" txt_f="6954"> approach is a more practical design. In contrast to measuring implementation non-response (or correlates of it) and not using it to guide improved implementation and outcomes, in adaptive implementation strategies, implementation interventions are augmented in direct response to limited adoption of EBPs among specific sites based on circumstances that may not be observable at baseline. This study addresses key scientific questions that need to be answered in order to develop an effective adaptive implementation strategy. Notably, among sites not responding to REP (i.e., not adopting the EBP), is it best to augment with REP + EF/IF or with REP + EF, or is it best to delay the provision of REP + EF/IF for sites that continue not to respond despite an initial REP + EF augmentation?</offsets></p><sec id="Sec2"><title><offsets xml_i="17451" xml_f="17470" txt_i="6955" txt_f="6974">Aims and objectives</offsets></title><p><offsets xml_i="17481" xml_f="17971" txt_i="6975" txt_f="7465">The overarching goal of this study is to build the most effective adaptive implementation strategy involving two cutting-edge implementation strategies (REP and Facilitation) to improve practice-level uptake of EBPs and patient outcomes. The EBP, life goals (LG), is an evidence-based psychosocial treatment delivered in six individual or group sessions that was shown in seven randomized controlled trials to improve mental and physical health outcomes among patients with mood disorders [</offsets><xref ref-type="bibr" rid="CR44"><offsets xml_i="18004" xml_f="18006" txt_i="7465" txt_f="7467">44</offsets></xref><offsets xml_i="18013" xml_f="18016" txt_i="7467" txt_f="7470">]-[</offsets><xref ref-type="bibr" rid="CR49"><offsets xml_i="18049" xml_f="18051" txt_i="7470" txt_f="7472">49</offsets></xref><offsets xml_i="18058" xml_f="18132" txt_i="7472" txt_f="7546">]. We will use a sequential multiple assignment randomized trial (SMART) [</offsets><xref ref-type="bibr" rid="CR50"><offsets xml_i="18165" xml_f="18167" txt_i="7546" txt_f="7548">50</offsets></xref><offsets xml_i="18174" xml_f="18177" txt_i="7548" txt_f="7551">],[</offsets><xref ref-type="bibr" rid="CR51"><offsets xml_i="18210" xml_f="18212" txt_i="7551" txt_f="7553">51</offsets></xref><offsets xml_i="18219" xml_f="18377" txt_i="7553" txt_f="7711">] design to build the adaptive intervention in which data on early response or non-response to REP will be used to determine the next implementation strategy.</offsets></p><sec id="Sec3"><title><offsets xml_i="18403" xml_f="18420" txt_i="7712" txt_f="7729">Primary study aim</offsets></title><p><offsets xml_i="18431" xml_f="18973" txt_i="7730" txt_f="8269">The primary aim of this study is to determine in a SMART implementation trial, among patients with mood disorders in sites that do not exhibit response to REP alone after 6 months (i.e., &lt;50% patients receive ≥3 LG sessions), the effect of adding an External and Internal Facilitator (REP + EF/IF) versus REP + EF on patient-level changes in mental health-related quality of life (MH-QOL; primary outcome), receipt of LG sessions, mood symptoms, implementation costs and organizational change (secondary outcomes) from month 6 to month 24.</offsets></p></sec><sec id="Sec4"><title><offsets xml_i="19005" xml_f="19020" txt_i="8271" txt_f="8286">Secondary aim 1</offsets></title><p><offsets xml_i="19031" xml_f="19300" txt_i="8287" txt_f="8556">The first secondary aim is to determine, among REP + EF sites that continue to exhibit non-response after an additional 6 months, the effect of continuing REP + EF vs. REP + EF/IF on patient-level changes in the primary and secondary outcomes from month 12 to month 24.</offsets></p></sec><sec id="Sec5"><title><offsets xml_i="19332" xml_f="19347" txt_i="8558" txt_f="8573">Secondary aim 2</offsets></title><p><offsets xml_i="19358" xml_f="19455" txt_i="8574" txt_f="8671">The second secondary aim is to estimate the site-level costs of REP + EF/IF compared to REP + EF.</offsets></p></sec><sec id="Sec6"><title><offsets xml_i="19487" xml_f="19502" txt_i="8673" txt_f="8688">Secondary aim 3</offsets></title><p><offsets xml_i="19513" xml_f="19741" txt_i="8689" txt_f="8917">The third secondary aim is to describe the implementation of EF and EF/IF at the site level, including interaction between the two roles and the specific strategies EFs and IFs use to facilitate LG uptake across different sites.</offsets></p><p><offsets xml_i="19748" xml_f="19946" txt_i="8918" txt_f="9116">The result of this current SMART study will be an optimized, adaptive implementation strategy that that could be applied to healthcare systems to improve outcomes for patients with mental disorders.</offsets></p></sec></sec></sec><sec id="Sec7"><title><offsets xml_i="19990" xml_f="19997" txt_i="9120" txt_f="9127">Methods</offsets></title><p><offsets xml_i="20008" xml_f="20067" txt_i="9128" txt_f="9187">This cluster randomized SMART implementation trial (Figure </offsets><xref rid="Fig2" ref-type="fig"><offsets xml_i="20099" xml_f="20100" txt_i="9187" txt_f="9188">2</offsets></xref><offsets xml_i="20107" xml_f="20339" txt_i="9188" txt_f="9420">) involves community-based clinics (sites) from Michigan (MI) and Colorado (CO) that care for persons with mood disorders (depression or bipolar disorders). This study was reviewed and approved the local institutional review boards.</offsets><fig id="Fig2"><label><offsets xml_i="20361" xml_f="20369" txt_i="9420" txt_f="9428">Figure 2</offsets></label><caption><p><offsets xml_i="20389" xml_f="20390" txt_i="9428" txt_f="9429">
</offsets><bold><offsets xml_i="20396" xml_f="20504" txt_i="9429" txt_f="9537">SMART trial design of REP combined with External (EF, REP + EF) and Internal Facilitation (IF, REP + EF/IF).</offsets></bold><offsets xml_i="20511" xml_f="20512" txt_i="9537" txt_f="9538">
</offsets></p></caption><graphic xlink:href="13012_2014_Article_132_Fig2_HTML" id="d30e711"></graphic></fig></p><sec id="Sec8"><title><offsets xml_i="20636" xml_f="20643" txt_i="9540" txt_f="9547">Setting</offsets></title><p><offsets xml_i="20654" xml_f="21042" txt_i="9548" txt_f="9936">Eighty community-based mental health or primary care clinics from the two states will be recruited to participate in the study based on lists of primary care and community mental health programs available from state organizations. Since the EBP to be implemented (LG) has been shown to be effective in improving outcomes across different settings (primary care, community mental health) [</offsets><xref ref-type="bibr" rid="CR45"><offsets xml_i="21075" xml_f="21077" txt_i="9936" txt_f="9938">45</offsets></xref><offsets xml_i="21084" xml_f="21087" txt_i="9938" txt_f="9941">]-[</offsets><xref ref-type="bibr" rid="CR47"><offsets xml_i="21120" xml_f="21122" txt_i="9941" txt_f="9943">47</offsets></xref><offsets xml_i="21129" xml_f="21132" txt_i="9943" txt_f="9946">],[</offsets><xref ref-type="bibr" rid="CR49"><offsets xml_i="21165" xml_f="21167" txt_i="9946" txt_f="9948">49</offsets></xref><offsets xml_i="21174" xml_f="21177" txt_i="9948" txt_f="9951">],[</offsets><xref ref-type="bibr" rid="CR52"><offsets xml_i="21210" xml_f="21212" txt_i="9951" txt_f="9953">52</offsets></xref><offsets xml_i="21219" xml_f="21300" txt_i="9953" txt_f="10034">], a diverse array of sites will be recruited to maximize study generalizability.</offsets></p></sec><sec id="Sec9"><title><offsets xml_i="21332" xml_f="21337" txt_i="10036" txt_f="10041">Sites</offsets></title><p><offsets xml_i="21348" xml_f="21394" txt_i="10042" txt_f="10088">Site inclusion criteria include the following:</offsets><list list-type="order"><list-item><p><offsets xml_i="21432" xml_f="21596" txt_i="10088" txt_f="10252">Community-based mental health or primary care clinic located in Michigan or Colorado with at least 100 unique patients diagnosed with or treated for mood disorders.</offsets></p></list-item><list-item><p><offsets xml_i="21626" xml_f="21923" txt_i="10253" txt_f="10550">Availability of a bachelor’s- or master’s-level healthcare provider with a mental health background and experience with implementing individual or group sessions (core modality of LG) who can be trained to provide LG to up to 20 adult patients with mood disorders in the clinic in a 1-year period.</offsets></p></list-item><list-item><p><offsets xml_i="21953" xml_f="22137" txt_i="10551" txt_f="10735">Availability of an employee at the site with direct reporting authority to the leadership of the site or parent practice organization who could serve as potential internal facilitator.</offsets></p></list-item></list></p></sec><sec id="Sec10"><title><offsets xml_i="22193" xml_f="22210" txt_i="10738" txt_f="10755">Study design flow</offsets></title><p><offsets xml_i="22221" xml_f="22440" txt_i="10756" txt_f="10975">Primary care or mental health outpatient clinics confirming eligibility using a standard organizational assessment and agreeing to participate will initially be offered REP for 6 months in order to implement LG (Figure </offsets><xref rid="Fig2" ref-type="fig"><offsets xml_i="22472" xml_f="22473" txt_i="10975" txt_f="10976">2</offsets></xref><offsets xml_i="22480" xml_f="22511" txt_i="10976" txt_f="11007">). Based on previous research [</offsets><xref ref-type="bibr" rid="CR53"><offsets xml_i="22544" xml_f="22546" txt_i="11007" txt_f="11009">53</offsets></xref><offsets xml_i="22553" xml_f="23137" txt_i="11009" txt_f="11590">] and preliminary data, it is expected that after 6 months of REP, at least 80% of sites will be non-responsive to REP. The primary focus of the randomized comparisons in this study are sites that are initially non-responsive to REP, defined based on our preliminary studies as &lt;50% of previously identified patients receiving at least three LG sessions (≥3 out of 6) to achieve minimum clinically significant results (85-89). Although not part of the primary randomized comparisons, sites that are responsive at 6 months will continue to be followed and outcomes will be assessed.</offsets></p></sec><sec id="Sec11"><title><offsets xml_i="23170" xml_f="23191" txt_i="11592" txt_f="11613">Patients within sites</offsets></title><p><offsets xml_i="23202" xml_f="23799" txt_i="11614" txt_f="12211">The unit of analysis is LG eligible patients within sites who are diagnosed with or treated for mood disorders. Patients are identified during the first 6 months as part of REP, i.e., prior to site-level randomization (see step 1 of REP below). Patient-level primary and secondary outcomes will be assessed by independent evaluators (i.e., study associates who are not aware of the assignment to REP + EF or REP + EF/IF) across all sites prior to identifying site response/non-response status at month 6, prior to identifying site response/non-response status at month 12, and at months 18 and 24.</offsets></p></sec><sec id="Sec12"><title><offsets xml_i="23832" xml_f="23850" txt_i="12213" txt_f="12231">Site randomization</offsets></title><p><offsets xml_i="23861" xml_f="24570" txt_i="12232" txt_f="12938">The unit of intervention (randomization) is the site. Sites that are not responding to REP at month 6 will be randomized 1:1 by the study data analyst to receive additional External Facilitation (REP + EF) or External plus Internal Facilitation (REP + EF/IF). After another 6 months (at month 12), (i) REP + EF sites that are still non-responsive (defined as &lt;50% patients receiving ≥3 life goals sessions) will be randomized 1:1 to either continue REP + EF or augmentation with IF (REP + EF/IF) for an additional 12 months, and (ii) intervention will be discontinued for sites that are responsive. The month 6 randomization will be stratified by state, practice type (primary care or mental health site) [</offsets><xref ref-type="bibr" rid="CR54"><offsets xml_i="24603" xml_f="24605" txt_i="12938" txt_f="12940">54</offsets></xref><offsets xml_i="24612" xml_f="24615" txt_i="12940" txt_f="12943">],[</offsets><xref ref-type="bibr" rid="CR55"><offsets xml_i="24648" xml_f="24650" txt_i="12943" txt_f="12945">55</offsets></xref><offsets xml_i="24657" xml_f="25338" txt_i="12945" txt_f="13623">], and by site-average baseline MH-QOL (e.g., low (&lt;40) vs. high (≥40)) at baseline. The month 12 randomization will be stratified by state, practice type, and site-average MH-QOL at month 12. This will ensure that intervention groups are balanced for site variables that may correlate highly with outcomes. The study analyst will generate the stratified permuted-block random allocation lists (blocks of size 2, 4, and 6) using a computer program such as PROC PLAN in SAS. Sites are expected to become eligible and accrue in groups of 6-12 (staggered entry). A site is considered randomized once the study analyst informs the study coordinator of each site’s random assignment.</offsets></p></sec><sec id="Sec13"><title><offsets xml_i="25371" xml_f="25412" txt_i="13625" txt_f="13666">Evidence-based practice to be implemented</offsets></title><p><offsets xml_i="25423" xml_f="25427" txt_i="13667" txt_f="13671">LG [</offsets><xref ref-type="bibr" rid="CR44"><offsets xml_i="25460" xml_f="25462" txt_i="13671" txt_f="13673">44</offsets></xref><offsets xml_i="25469" xml_f="25472" txt_i="13673" txt_f="13676">]-[</offsets><xref ref-type="bibr" rid="CR49"><offsets xml_i="25505" xml_f="25507" txt_i="13676" txt_f="13678">49</offsets></xref><offsets xml_i="25514" xml_f="25517" txt_i="13678" txt_f="13681">],[</offsets><xref ref-type="bibr" rid="CR52"><offsets xml_i="25550" xml_f="25552" txt_i="13681" txt_f="13683">52</offsets></xref><offsets xml_i="25559" xml_f="25664" txt_i="13683" txt_f="13788">] is a psychosocial intervention for mood disorders delivered in six individual or group sessions (Table </offsets><xref rid="Tab1" ref-type="table"><offsets xml_i="25698" xml_f="25699" txt_i="13788" txt_f="13789">1</offsets></xref><offsets xml_i="25706" xml_f="25743" txt_i="13789" txt_f="13826">). Based on social cognitive theory [</offsets><xref ref-type="bibr" rid="CR56"><offsets xml_i="25776" xml_f="25778" txt_i="13826" txt_f="13828">56</offsets></xref><offsets xml_i="25785" xml_f="25788" txt_i="13828" txt_f="13831">]-[</offsets><xref ref-type="bibr" rid="CR58"><offsets xml_i="25821" xml_f="25823" txt_i="13831" txt_f="13833">58</offsets></xref><offsets xml_i="25830" xml_f="26125" txt_i="13833" txt_f="14128">], LG encourages active discussions focused on individuals’ personal goals that are aligned with healthy behavior change and symptom management strategies. LG was chosen to be the EBP to implement because mood disorders are common in both community-based primary care and mental health clinics [</offsets><xref ref-type="bibr" rid="CR59"><offsets xml_i="26158" xml_f="26160" txt_i="14128" txt_f="14130">59</offsets></xref><offsets xml_i="26167" xml_f="26170" txt_i="14130" txt_f="14133">],[</offsets><xref ref-type="bibr" rid="CR60"><offsets xml_i="26203" xml_f="26205" txt_i="14133" txt_f="14135">60</offsets></xref><offsets xml_i="26212" xml_f="26410" txt_i="14135" txt_f="14333">], are considered to be high-priority populations based on input from community partners, and because LG was shown to improve outcomes including mental health-related quality of life in this group [</offsets><xref ref-type="bibr" rid="CR45"><offsets xml_i="26443" xml_f="26445" txt_i="14333" txt_f="14335">45</offsets></xref><offsets xml_i="26452" xml_f="26455" txt_i="14335" txt_f="14338">]-[</offsets><xref ref-type="bibr" rid="CR47"><offsets xml_i="26488" xml_f="26490" txt_i="14338" txt_f="14340">47</offsets></xref><offsets xml_i="26497" xml_f="26500" txt_i="14340" txt_f="14343">],[</offsets><xref ref-type="bibr" rid="CR49"><offsets xml_i="26533" xml_f="26535" txt_i="14343" txt_f="14345">49</offsets></xref><offsets xml_i="26542" xml_f="26545" txt_i="14345" txt_f="14348">],[</offsets><xref ref-type="bibr" rid="CR52"><offsets xml_i="26578" xml_f="26580" txt_i="14348" txt_f="14350">52</offsets></xref><offsets xml_i="26587" xml_f="26718" txt_i="14350" txt_f="14481">]. Compared to usual care, LG improved outcomes among a cross-diagnosis sample of community-based outpatients with mood disorders [</offsets><xref ref-type="bibr" rid="CR45"><offsets xml_i="26751" xml_f="26753" txt_i="14481" txt_f="14483">45</offsets></xref><offsets xml_i="26760" xml_f="26763" txt_i="14483" txt_f="14486">]-[</offsets><xref ref-type="bibr" rid="CR49"><offsets xml_i="26796" xml_f="26798" txt_i="14486" txt_f="14488">49</offsets></xref><offsets xml_i="26805" xml_f="26808" txt_i="14488" txt_f="14491">],[</offsets><xref ref-type="bibr" rid="CR52"><offsets xml_i="26841" xml_f="26843" txt_i="14491" txt_f="14493">52</offsets></xref><offsets xml_i="26850" xml_f="26978" txt_i="14493" txt_f="14621">], notably a four-point increase in mental and physical health-related quality of life scores based on the SF-12 (e.g., Cohen’s </offsets><italic><offsets xml_i="26986" xml_f="26987" txt_i="14621" txt_f="14622">D</offsets></italic><offsets xml_i="26996" xml_f="27005" txt_i="14622" txt_f="14631"> = .36) [</offsets><xref ref-type="bibr" rid="CR45"><offsets xml_i="27038" xml_f="27040" txt_i="14631" txt_f="14633">45</offsets></xref><offsets xml_i="27047" xml_f="27050" txt_i="14633" txt_f="14636">],[</offsets><xref ref-type="bibr" rid="CR46"><offsets xml_i="27083" xml_f="27085" txt_i="14636" txt_f="14638">46</offsets></xref><offsets xml_i="27092" xml_f="27095" txt_i="14638" txt_f="14641">],[</offsets><xref ref-type="bibr" rid="CR49"><offsets xml_i="27128" xml_f="27130" txt_i="14641" txt_f="14643">49</offsets></xref><offsets xml_i="27137" xml_f="27253" txt_i="14643" txt_f="14759">]. LG has been shown to be equally effective in patients with co-occurring substance use and medical comorbidities [</offsets><xref ref-type="bibr" rid="CR46"><offsets xml_i="27286" xml_f="27288" txt_i="14759" txt_f="14761">46</offsets></xref><offsets xml_i="27295" xml_f="27298" txt_i="14761" txt_f="14764">],[</offsets><xref ref-type="bibr" rid="CR47"><offsets xml_i="27331" xml_f="27333" txt_i="14764" txt_f="14766">47</offsets></xref><offsets xml_i="27340" xml_f="27343" txt_i="14766" txt_f="14769">],[</offsets><xref ref-type="bibr" rid="CR49"><offsets xml_i="27376" xml_f="27378" txt_i="14769" txt_f="14771">49</offsets></xref><offsets xml_i="27385" xml_f="27388" txt_i="14771" txt_f="14774">],[</offsets><xref ref-type="bibr" rid="CR52"><offsets xml_i="27421" xml_f="27423" txt_i="14774" txt_f="14776">52</offsets></xref><offsets xml_i="27430" xml_f="27433" txt_i="14776" txt_f="14779">],[</offsets><xref ref-type="bibr" rid="CR61"><offsets xml_i="27466" xml_f="27468" txt_i="14779" txt_f="14781">61</offsets></xref><offsets xml_i="27475" xml_f="27524" txt_i="14781" txt_f="14830">]. Community-based providers helped to adapt LG [</offsets><xref ref-type="bibr" rid="CR46"><offsets xml_i="27557" xml_f="27559" txt_i="14830" txt_f="14832">46</offsets></xref><offsets xml_i="27566" xml_f="27569" txt_i="14832" txt_f="14835">]-[</offsets><xref ref-type="bibr" rid="CR48"><offsets xml_i="27602" xml_f="27604" txt_i="14835" txt_f="14837">48</offsets></xref><offsets xml_i="27611" xml_f="27705" txt_i="14837" txt_f="14931">], but as with many psychosocial EBPs, have not been widely implemented in smaller practices [</offsets><xref ref-type="bibr" rid="CR62"><offsets xml_i="27738" xml_f="27740" txt_i="14931" txt_f="14933">62</offsets></xref><offsets xml_i="27747" xml_f="27749" txt_i="14933" txt_f="14935">].</offsets><table-wrap id="Tab1"><label><offsets xml_i="27778" xml_f="27785" txt_i="14935" txt_f="14942">Table 1</offsets></label><caption><p><offsets xml_i="27805" xml_f="27806" txt_i="14942" txt_f="14943">
</offsets><bold><offsets xml_i="27812" xml_f="27848" txt_i="14943" txt_f="14979">Components of the life goals program</offsets></bold><offsets xml_i="27855" xml_f="27856" txt_i="14979" txt_f="14980">
</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th><offsets xml_i="27922" xml_f="27931" txt_i="14981" txt_f="14990">Component</offsets></th><th><offsets xml_i="27940" xml_f="28001" txt_i="14990" txt_f="15051">Description/core concepts across all self-management sessions</offsets></th></tr></thead><tbody><tr><td><offsets xml_i="28034" xml_f="28058" txt_i="15051" txt_f="15075">Self-management sessions</offsets></td><td><offsets xml_i="28067" xml_f="28274" txt_i="15076" txt_f="15283">A minimum of six individual sessions lasting ~50 min each or four group sessions lasting ~90 min each focused on active discussions around personal goals, mental health symptoms, stigma, and health behaviors</offsets></td></tr><tr><td><offsets xml_i="28292" xml_f="28298" txt_i="15284" txt_f="15290">Values</offsets></td><td><offsets xml_i="28307" xml_f="28437" txt_i="15291" txt_f="15421">Explore personal values and their relationship to health change behavior; also explore types of stigma and ways to overcome stigma</offsets></td></tr><tr><td><offsets xml_i="28455" xml_f="28473" txt_i="15422" txt_f="15440">Collaborative care</offsets></td><td><offsets xml_i="28482" xml_f="28713" txt_i="15441" txt_f="15672">Identify ways to strengthen relationships and participation in healthcare, explore the importance of coming prepared to medical visits, and identify ways to ensure true collaboration is occurring to support optimal health outcomes.</offsets></td></tr><tr><td><offsets xml_i="28731" xml_f="28746" txt_i="15673" txt_f="15688">Self-monitoring</offsets></td><td><offsets xml_i="28755" xml_f="28947" txt_i="15689" txt_f="15881">Discuss the importance of measurement-based care and develop a meaningful self-monitoring plan for identified mental or physical health condition (i.e., PHQ-9, GAD-7, sleep log, food tracking)</offsets></td></tr><tr><td><offsets xml_i="28965" xml_f="28980" txt_i="15882" txt_f="15897">Symptom profile</offsets></td><td><offsets xml_i="28989" xml_f="29174" txt_i="15898" txt_f="16083">Create a personal symptom profile for a specific mental health condition with a focus on identifying early warning signs and ways to use this knowledge to bolster self-management skills</offsets></td></tr><tr><td><offsets xml_i="29192" xml_f="29200" txt_i="16084" txt_f="16092">Triggers</offsets></td><td><offsets xml_i="29209" xml_f="29333" txt_i="16093" txt_f="16217">Identify positive and negative, preventable and inevitable triggers and ways to better prepare for and manage these triggers</offsets></td></tr><tr><td><offsets xml_i="29351" xml_f="29385" txt_i="16218" txt_f="16252">Cost/benefit analysis of responses</offsets></td><td><offsets xml_i="29394" xml_f="29508" txt_i="16253" txt_f="16367">Explore previous responses to psychiatric symptoms and link responses to personal values and behavior change goals</offsets></td></tr><tr><td><offsets xml_i="29526" xml_f="29536" txt_i="16368" txt_f="16378">Life goals</offsets></td><td><offsets xml_i="29545" xml_f="29649" txt_i="16379" txt_f="16483">Create SMART goals, problem-solve barriers, and ensure personal goals are in line with identified values</offsets></td></tr><tr><td><offsets xml_i="29667" xml_f="29682" txt_i="16484" txt_f="16499">Care management</offsets></td><td><offsets xml_i="29691" xml_f="29938" txt_i="16500" txt_f="16747">At least monthly (for 6 months) individualized follow-up contacts to support lessons learned; contacts work to problem-solve barriers to health-behavior goals and provide additional support for mental health issues interfering with goal attainment</offsets></td></tr><tr><td><offsets xml_i="29956" xml_f="29981" txt_i="16748" txt_f="16773">Provider decision support</offsets></td><td><offsets xml_i="29990" xml_f="30117" txt_i="16774" txt_f="16901">Knowledge and availability of best practice treatments for mental and physical health conditions either in-house or via consult</offsets></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec14"><title><offsets xml_i="30189" xml_f="30214" txt_i="16904" txt_f="16929">Implementation strategies</offsets></title><sec id="Sec15"><title><offsets xml_i="30245" xml_f="30248" txt_i="16930" txt_f="16933">REP</offsets></title><p><offsets xml_i="30259" xml_f="30293" txt_i="16934" txt_f="16968">All sites will receive REP (Table </offsets><xref rid="Tab2" ref-type="table"><offsets xml_i="30327" xml_f="30328" txt_i="16968" txt_f="16969">2</offsets></xref><offsets xml_i="30335" xml_f="30473" txt_i="16969" txt_f="17107">) in the first 6 months. REP is based on the Centers for Disease Control and Prevention’s (CDC’s) Research to Practice Framework project [</offsets><xref ref-type="bibr" rid="CR35"><offsets xml_i="30506" xml_f="30508" txt_i="17107" txt_f="17109">35</offsets></xref><offsets xml_i="30515" xml_f="30518" txt_i="17109" txt_f="17112">],[</offsets><xref ref-type="bibr" rid="CR62"><offsets xml_i="30551" xml_f="30553" txt_i="17112" txt_f="17114">62</offsets></xref><offsets xml_i="30560" xml_f="30563" txt_i="17114" txt_f="17117">],[</offsets><xref ref-type="bibr" rid="CR63"><offsets xml_i="30596" xml_f="30598" txt_i="17117" txt_f="17119">63</offsets></xref><offsets xml_i="30605" xml_f="30844" txt_i="17119" txt_f="17358">] and includes initial marketing of the LG program by study investigators, package dissemination and training by an off-site trainer, as-needed program support in using LG (program assistance), and LG uptake monitoring for up to 6 months [</offsets><xref ref-type="bibr" rid="CR35"><offsets xml_i="30877" xml_f="30879" txt_i="17358" txt_f="17360">35</offsets></xref><offsets xml_i="30886" xml_f="30889" txt_i="17360" txt_f="17363">],[</offsets><xref ref-type="bibr" rid="CR44"><offsets xml_i="30922" xml_f="30924" txt_i="17363" txt_f="17365">44</offsets></xref><offsets xml_i="30931" xml_f="30963" txt_i="17365" txt_f="17397">]. The theories underlying REP [</offsets><xref ref-type="bibr" rid="CR64"><offsets xml_i="30996" xml_f="30998" txt_i="17397" txt_f="17399">64</offsets></xref><offsets xml_i="31005" xml_f="31008" txt_i="17399" txt_f="17402">],[</offsets><xref ref-type="bibr" rid="CR65"><offsets xml_i="31041" xml_f="31043" txt_i="17402" txt_f="17404">65</offsets></xref><offsets xml_i="31050" xml_f="31094" txt_i="17404" txt_f="17448">] include Rogers’ Diffusion of Innovations [</offsets><xref ref-type="bibr" rid="CR36"><offsets xml_i="31127" xml_f="31129" txt_i="17448" txt_f="17450">36</offsets></xref><offsets xml_i="31136" xml_f="31166" txt_i="17450" txt_f="17480">] and Social Learning Theory [</offsets><xref ref-type="bibr" rid="CR66"><offsets xml_i="31199" xml_f="31201" txt_i="17480" txt_f="17482">66</offsets></xref><offsets xml_i="31208" xml_f="31265" txt_i="17482" txt_f="17539">]. For this study, REP includes the following components:</offsets><table-wrap id="Tab2"><label><offsets xml_i="31294" xml_f="31301" txt_i="17539" txt_f="17546">Table 2</offsets></label><caption><p><offsets xml_i="31321" xml_f="31322" txt_i="17546" txt_f="17547">
</offsets><bold><offsets xml_i="31328" xml_f="31468" txt_i="17547" txt_f="17687">Description of REP, REP + EF, and REP + EF/IF implementation strategies to enhance the uptake of the life goals (LG) evidence-based practice</offsets></bold><offsets xml_i="31475" xml_f="31476" txt_i="17687" txt_f="17688">
</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th><offsets xml_i="31542" xml_f="31566" txt_i="17689" txt_f="17713">Implementation component</offsets></th><th><offsets xml_i="31575" xml_f="31578" txt_i="17713" txt_f="17716">REP</offsets></th><th><offsets xml_i="31587" xml_f="31595" txt_i="17716" txt_f="17724">REP + EF</offsets></th><th><offsets xml_i="31604" xml_f="31615" txt_i="17724" txt_f="17735">REP + EF/IF</offsets></th></tr><tr><th><offsets xml_i="31633" xml_f="31642" txt_i="17735" txt_f="17744">REP (REP)</offsets></th><th><offsets xml_i="31651" xml_f="31660" txt_i="17744" txt_f="17753">All sites</offsets></th><th><offsets xml_i="31669" xml_f="31702" txt_i="17753" txt_f="17786">Randomize to non-responding sites</offsets></th><th><offsets xml_i="31711" xml_f="31744" txt_i="17786" txt_f="17819">Randomize to non-responding sites</offsets></th></tr></thead><tbody><tr><td><offsets xml_i="31777" xml_f="32126" txt_i="17819" txt_f="18168">Step 1: Market LG, disseminate LG package. (a) Marketing (pre-implementation): hold pre-implementation meetings with site representatives to describe the benefits of LG and identify potential LG providers and internal facilitators (IF). (b) Dissemination: regional in-services to disseminate LG implementation guide to providers, schedule trainings.</offsets></td><td><offsets xml_i="32135" xml_f="32136" txt_i="18169" txt_f="18170">
</offsets><bold><offsets xml_i="32142" xml_f="32143" txt_i="18170" txt_f="18171">√</offsets></bold><offsets xml_i="32150" xml_f="32151" txt_i="18171" txt_f="18172">
</offsets></td><td><offsets xml_i="32160" xml_f="32161" txt_i="18173" txt_f="18174">
</offsets><bold><offsets xml_i="32167" xml_f="32168" txt_i="18174" txt_f="18175">√</offsets></bold><offsets xml_i="32175" xml_f="32176" txt_i="18175" txt_f="18176">
</offsets></td><td><offsets xml_i="32185" xml_f="32186" txt_i="18177" txt_f="18178">
</offsets><bold><offsets xml_i="32192" xml_f="32193" txt_i="18178" txt_f="18179">√</offsets></bold><offsets xml_i="32200" xml_f="32201" txt_i="18179" txt_f="18180">
</offsets></td></tr><tr><td><offsets xml_i="32219" xml_f="32415" txt_i="18181" txt_f="18377">Step 2: Train site providers in LG. Conduct regionalized 8-h training for LG providers covering LG session content and delivery via LG website as well as patient tracking and monitoring over time.</offsets></td><td><offsets xml_i="32424" xml_f="32425" txt_i="18378" txt_f="18379">
</offsets><bold><offsets xml_i="32431" xml_f="32432" txt_i="18379" txt_f="18380">√</offsets></bold><offsets xml_i="32439" xml_f="32440" txt_i="18380" txt_f="18381">
</offsets></td><td><offsets xml_i="32449" xml_f="32450" txt_i="18382" txt_f="18383">
</offsets><bold><offsets xml_i="32456" xml_f="32457" txt_i="18383" txt_f="18384">√</offsets></bold><offsets xml_i="32464" xml_f="32465" txt_i="18384" txt_f="18385">
</offsets></td><td><offsets xml_i="32474" xml_f="32475" txt_i="18386" txt_f="18387">
</offsets><bold><offsets xml_i="32481" xml_f="32482" txt_i="18387" txt_f="18388">√</offsets></bold><offsets xml_i="32489" xml_f="32490" txt_i="18388" txt_f="18389">
</offsets></td></tr><tr><td><offsets xml_i="32508" xml_f="32609" txt_i="18390" txt_f="18491">Step 3: As-needed program assistance and LG uptake monitoring via secure web-based reporting sheets. </offsets><italic><offsets xml_i="32617" xml_f="32623" txt_i="18491" txt_f="18497">Ad hoc</offsets></italic><offsets xml_i="32632" xml_f="32694" txt_i="18497" txt_f="18559"> program support available by study program support assistant.</offsets></td><td><offsets xml_i="32703" xml_f="32704" txt_i="18560" txt_f="18561">
</offsets><bold><offsets xml_i="32710" xml_f="32711" txt_i="18561" txt_f="18562">√</offsets></bold><offsets xml_i="32718" xml_f="32719" txt_i="18562" txt_f="18563">
</offsets></td><td><offsets xml_i="32728" xml_f="32729" txt_i="18564" txt_f="18565">
</offsets><bold><offsets xml_i="32735" xml_f="32736" txt_i="18565" txt_f="18566">√</offsets></bold><offsets xml_i="32743" xml_f="32744" txt_i="18566" txt_f="18567">
</offsets></td><td><offsets xml_i="32753" xml_f="32754" txt_i="18568" txt_f="18569">
</offsets><bold><offsets xml_i="32760" xml_f="32761" txt_i="18569" txt_f="18570">√</offsets></bold><offsets xml_i="32768" xml_f="32769" txt_i="18570" txt_f="18571">
</offsets></td></tr><tr><td><offsets xml_i="32787" xml_f="32824" txt_i="18572" txt_f="18609">REP + External Facilitator (REP + EF)</offsets></td><td></td><td></td><td></td></tr><tr><td><offsets xml_i="32869" xml_f="33092" txt_i="18613" txt_f="18836">Step 1: Initiation and benchmarking: EF contacts each LG provider, works with LG provider to identify potential barriers and facilitators to LG uptake from the LG provider’s perspective, and sets measurable goals to uptake.</offsets></td><td></td><td><offsets xml_i="33110" xml_f="33111" txt_i="18838" txt_f="18839">
</offsets><bold><offsets xml_i="33117" xml_f="33118" txt_i="18839" txt_f="18840">√</offsets></bold><offsets xml_i="33125" xml_f="33126" txt_i="18840" txt_f="18841">
</offsets></td><td><offsets xml_i="33135" xml_f="33136" txt_i="18842" txt_f="18843">
</offsets><bold><offsets xml_i="33142" xml_f="33143" txt_i="18843" txt_f="18844">√</offsets></bold><offsets xml_i="33150" xml_f="33151" txt_i="18844" txt_f="18845">
</offsets></td></tr><tr><td><offsets xml_i="33169" xml_f="33488" txt_i="18846" txt_f="19165">Step 2: Coaching: EF makes calls on a biweekly basis to site’s LG providers to develop rapport and provide specific guidance on overcoming barriers in implementing LG components by aligning LG’s strengths with LG’s available influence at the site. If needed, EF refers LG provider to study LG program support assistant.</offsets></td><td></td><td><offsets xml_i="33506" xml_f="33507" txt_i="19167" txt_f="19168">
</offsets><bold><offsets xml_i="33513" xml_f="33514" txt_i="19168" txt_f="19169">√</offsets></bold><offsets xml_i="33521" xml_f="33522" txt_i="19169" txt_f="19170">
</offsets></td><td><offsets xml_i="33531" xml_f="33532" txt_i="19171" txt_f="19172">
</offsets><bold><offsets xml_i="33538" xml_f="33539" txt_i="19172" txt_f="19173">√</offsets></bold><offsets xml_i="33546" xml_f="33547" txt_i="19173" txt_f="19174">
</offsets></td></tr><tr><td><offsets xml_i="33565" xml_f="33733" txt_i="19175" txt_f="19343">Step 3: Public recognition of “bright spots” (high-performing sites): EF provides state-specific report on sites’ progress and disseminates LG provider success stories.</offsets></td><td></td><td><offsets xml_i="33751" xml_f="33752" txt_i="19345" txt_f="19346">
</offsets><bold><offsets xml_i="33758" xml_f="33759" txt_i="19346" txt_f="19347">√</offsets></bold><offsets xml_i="33766" xml_f="33767" txt_i="19347" txt_f="19348">
</offsets></td><td><offsets xml_i="33776" xml_f="33777" txt_i="19349" txt_f="19350">
</offsets><bold><offsets xml_i="33783" xml_f="33784" txt_i="19350" txt_f="19351">√</offsets></bold><offsets xml_i="33791" xml_f="33792" txt_i="19351" txt_f="19352">
</offsets></td></tr><tr><td><offsets xml_i="33810" xml_f="33863" txt_i="19353" txt_f="19406">REP + External and Internal Facilitator (REP + EF/IF)</offsets></td><td></td><td></td><td></td></tr><tr><td><offsets xml_i="33908" xml_f="34134" txt_i="19410" txt_f="19636">Step 1: Initiation and benchmarking: EF contacts each LG provider and holds call with LG provider and IF to give background on LG, review potential barriers and facilitators to LG uptake, and set measurable goals to LG uptake.</offsets></td><td></td><td></td><td><offsets xml_i="34161" xml_f="34162" txt_i="19639" txt_f="19640">
</offsets><bold><offsets xml_i="34168" xml_f="34169" txt_i="19640" txt_f="19641">√</offsets></bold><offsets xml_i="34176" xml_f="34177" txt_i="19641" txt_f="19642">
</offsets></td></tr><tr><td><offsets xml_i="34195" xml_f="34509" txt_i="19643" txt_f="19957">Step 2: Leveraging: IF meets with LG provider biweekly, identifies local site priorities per leadership input, identifies other LG program champions, and helps LG provider summarize and describe added value of LG to leadership and site providers (e.g., consistency with other initiatives, support from leadership).</offsets></td><td></td><td></td><td><offsets xml_i="34536" xml_f="34537" txt_i="19960" txt_f="19961">
</offsets><bold><offsets xml_i="34543" xml_f="34544" txt_i="19961" txt_f="19962">√</offsets></bold><offsets xml_i="34551" xml_f="34552" txt_i="19962" txt_f="19963">
</offsets></td></tr><tr><td><offsets xml_i="34570" xml_f="34967" txt_i="19964" txt_f="20361">Step 3: Coaching: IF, EF, and LG hold biweekly calls to develop rapport; EF provides guidance to LG on overcoming specific barriers to LG uptake by aligning LG’s strengths with LG’s available influence at the site (EF), and IF aligns goals of LG provider with existing site priorities, based on feedback from site leadership. If needed, EF refers LG provider to study LG program support assistant.</offsets></td><td></td><td></td><td><offsets xml_i="34994" xml_f="34995" txt_i="20364" txt_f="20365">
</offsets><bold><offsets xml_i="35001" xml_f="35002" txt_i="20365" txt_f="20366">√</offsets></bold><offsets xml_i="35009" xml_f="35010" txt_i="20366" txt_f="20367">
</offsets></td></tr><tr><td><offsets xml_i="35028" xml_f="35152" txt_i="20368" txt_f="20492">Step 4: Ongoing marketing: IF, leadership, and LG provider summarize progress and develop business and sustainability plans.</offsets></td><td></td><td></td><td><offsets xml_i="35179" xml_f="35180" txt_i="20495" txt_f="20496">
</offsets><bold><offsets xml_i="35186" xml_f="35187" txt_i="20496" txt_f="20497">√</offsets></bold><offsets xml_i="35194" xml_f="35195" txt_i="20497" txt_f="20498">
</offsets></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec16"><title><offsets xml_i="35267" xml_f="35351" txt_i="20501" txt_f="20585">Step 1: marketing and dissemination of LG package, in-service, and patient selection</offsets></title><p><offsets xml_i="35362" xml_f="35728" txt_i="20586" txt_f="20952">Regional in-services will first be provided by study investigators who will give an overview of LG including the evidence, and details on how to implement LG in their setting. Each site will designate at least one provider with a mental health background to implement LG (“LG provider”), and the LG package will be disseminated by the REP trainer to these providers.</offsets></p><p><offsets xml_i="35735" xml_f="36639" txt_i="20953" txt_f="21857">The LG REP package includes all of the components needed to implement LG, including the LG provider manual; a protocol for identifying patients to enroll in LG; LG session scripts and focus points covered in each session in a semi-directed fashion; the registry template for tracking enrolled patients’ progress in LG session-based personal goals, symptoms, and health behavior change; scripts for follow-up calls, patient workbooks, and an implementation manual describing logistics (e.g., identifying rooms if group sessions are used, identifying patients for LG, medical record templates for LG sessions, billing codes). Because LG effectiveness was already demonstrated in patients with mood disorders and that the primary goal of the study is to promote LG implementation, LG providers will identify and offer LG to patients at their site with mood disorders based on guidance from the REP trainer [</offsets><xref ref-type="bibr" rid="CR44"><offsets xml_i="36672" xml_f="36674" txt_i="21857" txt_f="21859">44</offsets></xref><offsets xml_i="36681" xml_f="36684" txt_i="21859" txt_f="21862">],[</offsets><xref ref-type="bibr" rid="CR62"><offsets xml_i="36717" xml_f="36719" txt_i="21862" txt_f="21864">62</offsets></xref><offsets xml_i="36726" xml_f="36934" txt_i="21864" txt_f="22072">]. The trainer will work with LG providers to identify up to 30 patients within a 3-month period who are appropriate for the LG program using the following criteria that are included in the registry template:</offsets><list list-type="order"><list-item><p><offsets xml_i="36972" xml_f="37160" txt_i="22072" txt_f="22260">adults 21 years or older with a diagnosis and current documentation of antidepressant or mood stabilizer for a mood disorder (depression or bipolar disorder) based on medical record review</offsets></p></list-item><list-item><p><offsets xml_i="37190" xml_f="37237" txt_i="22261" txt_f="22308">not currently enrolled in residential treatment</offsets></p></list-item><list-item><p><offsets xml_i="37267" xml_f="37457" txt_i="22309" txt_f="22499">can understand English and have no terminal illness or cognitive impairment that precludes participation in outpatient psychosocial treatment based on confirmation by the treating clinician.</offsets></p></list-item></list></p><p><offsets xml_i="37487" xml_f="37533" txt_i="22501" txt_f="22547">Assuming a 33% refusal or ineligibility rate [</offsets><xref ref-type="bibr" rid="CR47"><offsets xml_i="37566" xml_f="37568" txt_i="22547" txt_f="22549">47</offsets></xref><offsets xml_i="37575" xml_f="37659" txt_i="22549" txt_f="22633">], as well as a potential 12-month attrition rate of around 20% from prior studies [</offsets><xref ref-type="bibr" rid="CR47"><offsets xml_i="37692" xml_f="37694" txt_i="22633" txt_f="22635">47</offsets></xref><offsets xml_i="37701" xml_f="37865" txt_i="22635" txt_f="22799">], LG providers will be expected to identify and initially offer LG to 30 patients, assuming 20 will initially participate, with 16 to complete 12-month follow-ups.</offsets></p></sec><sec id="Sec17"><title><offsets xml_i="37898" xml_f="37945" txt_i="22801" txt_f="22848">Step 2: REP LG training and provider competency</offsets></title><p><offsets xml_i="37956" xml_f="38065" txt_i="22849" txt_f="22958">LG providers will undergo a 1-day training program that has been provided to over 200 clinicians nationally [</offsets><xref ref-type="bibr" rid="CR44"><offsets xml_i="38098" xml_f="38100" txt_i="22958" txt_f="22960">44</offsets></xref><offsets xml_i="38107" xml_f="38110" txt_i="22960" txt_f="22963">],[</offsets><xref ref-type="bibr" rid="CR67"><offsets xml_i="38143" xml_f="38145" txt_i="22963" txt_f="22965">67</offsets></xref><offsets xml_i="38152" xml_f="38155" txt_i="22965" txt_f="22968">]-[</offsets><xref ref-type="bibr" rid="CR69"><offsets xml_i="38188" xml_f="38190" txt_i="22968" txt_f="22970">69</offsets></xref><offsets xml_i="38197" xml_f="38606" txt_i="22970" txt_f="23379">]. The LG trainer will first provide an orientation to the evidence behind LG and core elements and then a step-by-step walk-through of LG components. The trainer will then demonstrate each LG session and follow-up contact procedures, as well as the standardized criteria for identifying patients who are appropriate for LG in routine practice. LG providers will break into groups and practice each component.</offsets></p><p><offsets xml_i="38613" xml_f="39806" txt_i="23380" txt_f="24573">After identifying eligible patients, LG providers will make an initial contact to each patient, introduce the LG program, and schedule in-person group or individual sessions. Individual sessions typically last 50 min each, while group sessions typically last around 90 min to allow for additional discussions between group members. Participants can make up sessions over the phone if they are unable to make in-person sessions. In the sessions, the LG provider will encourage active discussions that progressively have participants identify a personal symptom profile and triggers to the mood symptom or episode and develop an activity plan for identifying warning signs of symptoms and an activity plan for adopting a specific health behavior to mitigate symptoms and promote wellness. Participants will be given a workbook with exercises on behavior change goals, symptom assessments, and coping strategies. The LG provider will also make individual contacts to patients after the end of the sessions on a regular basis to review symptoms and behavior change. LG providers are trained to handle patients with elevated symptoms or suicidal ideation as part of their clinical responsibilities.</offsets></p></sec><sec id="Sec18"><title><offsets xml_i="39839" xml_f="39897" txt_i="24575" txt_f="24633">Step 3: As-needed REP program assistance and LG monitoring</offsets></title><p><offsets xml_i="39908" xml_f="40700" txt_i="24634" txt_f="25426">The final phase of REP consists of as-needed program assistance provided to LG clinicians who contact the LG program support specialist. In addition, each LG provider is sent a standard monitoring form on a biweekly basis for up to 6 months to have them record the number of patients approached and number receiving each LG session. Monitoring forms will be used to assess non-response across sites and will be corroborated based on patient self-reported LG use from the follow-up surveys (see data collection below). Sites will receive feedback reports from the program support assistant that includes performance on uptake measures (i.e., how many enrolled, how many sessions) in comparison to other sites. Also, sites will receive periodic (quarterly) newsletters about the study progress.</offsets></p></sec><sec id="Sec19"><title><offsets xml_i="40733" xml_f="40745" txt_i="25428" txt_f="25440">Facilitation</offsets></title><p><offsets xml_i="40756" xml_f="40830" txt_i="25441" txt_f="25515">The Facilitation implementation strategy will consist of EF and IF (Table </offsets><xref rid="Tab2" ref-type="table"><offsets xml_i="40864" xml_f="40865" txt_i="25515" txt_f="25516">2</offsets></xref><offsets xml_i="40872" xml_f="40971" txt_i="25516" txt_f="25615">). Based on the Promoting Action on Research Implementation in Health Services (PARiHS) Framework [</offsets><xref ref-type="bibr" rid="CR70"><offsets xml_i="41004" xml_f="41006" txt_i="25615" txt_f="25617">70</offsets></xref><offsets xml_i="41013" xml_f="41016" txt_i="25617" txt_f="25620">]-[</offsets><xref ref-type="bibr" rid="CR74"><offsets xml_i="41049" xml_f="41051" txt_i="25620" txt_f="25622">74</offsets></xref><offsets xml_i="41058" xml_f="41252" txt_i="25622" txt_f="25816">], facilitation is defined as the process of interactive problem solving and support that occurs in the context of a recognized need for improvement and a supportive interpersonal relationship [</offsets><xref ref-type="bibr" rid="CR41"><offsets xml_i="41285" xml_f="41287" txt_i="25816" txt_f="25818">41</offsets></xref><offsets xml_i="41294" xml_f="41297" txt_i="25818" txt_f="25821">],[</offsets><xref ref-type="bibr" rid="CR74"><offsets xml_i="41330" xml_f="41332" txt_i="25821" txt_f="25823">74</offsets></xref><offsets xml_i="41339" xml_f="41341" txt_i="25823" txt_f="25825">].</offsets></p><p><offsets xml_i="41348" xml_f="42194" txt_i="25826" txt_f="26672">LG providers from sites that are not responsive to REP in 6 months after initiating LG at their site will be randomized to receive REP + EF or REP + EF/IF. Sites receiving REP + EF will be contacted by the EF, who resides off site. The EF will contact individual providers from each site on a regular basis and conduct 1-hour phone calls to provide guidance on implementing LG components. Notably, the EF will be trained to identify individual strengths of each LG provider and help leverage those strengths with available influence the LG provider has at the site. The EF will also set measurable objectives in implementing LG (e.g., number of patients completing at least one group session), review implementation progress, and where appropriate, refer the provider to the study program support assistant for specific guidance on LG use (Table </offsets><xref rid="Tab2" ref-type="table"><offsets xml_i="42228" xml_f="42229" txt_i="26672" txt_f="26673">2</offsets></xref><offsets xml_i="42236" xml_f="42238" txt_i="26673" txt_f="26675">).</offsets></p><p><offsets xml_i="42245" xml_f="43081" txt_i="26676" txt_f="27512">LG providers from sites that are not responsive to REP initially and randomized to receive REP + EF/IF will also be contacted by the EF, and the study team will also contact the site to identify an IF at the time of randomization. The IF will be an individual supervising the LG provider in some capacity. In this arm, LG providers will have regular calls with the EF and IF, as well as meet with IF one on one on a regular basis. As with the REP + EF arm, EFs will identify the individual strengths of each LG provider and help leverage those strengths with available influence the LG provider has at the site. In addition, the IF at each site will meet with the LG provider and will use their internal knowledge of the site to help the LG provider identify opportunities to align LG program goals with existing site priorities (Table </offsets><xref rid="Tab2" ref-type="table"><offsets xml_i="43115" xml_f="43116" txt_i="27512" txt_f="27513">2</offsets></xref><offsets xml_i="43123" xml_f="43208" txt_i="27513" txt_f="27598">). Sites randomized to receive IF will receive up to $5,500 to cover IF-related time.</offsets></p></sec></sec><sec id="Sec20"><title><offsets xml_i="43247" xml_f="43293" txt_i="27601" txt_f="27647">Ensuring fidelity to implementation strategies</offsets></title><p><offsets xml_i="43304" xml_f="44002" txt_i="27648" txt_f="28346">Fidelity monitoring will be used to assess whether each site is receiving the core components of each implementation strategy (REP, EF, and IF) and to ensure that there is no contamination across roles. Data from LG provider logs and EF/IF activities completed by study staff will be used to ascertain fidelity within each 6-month period of implementation strategy exposure using established checklists. All sites will get the same LG REP package, and LG training will be conducted by the study trainer who will hold regional trainings in each state. The EF will be trained by study investigators based on a 2-day training program developed for national roll-out of both the REP and EF/IF programs.</offsets></p><p><offsets xml_i="44009" xml_f="44315" txt_i="28347" txt_f="28653">Fidelity to REP is defined based on number of sites receiving an LG package, number of providers completing the 1-day LG training program, and number of completed lists of patients receiving LG. Fidelity to the EF role will be defined using the following criteria based on the components outlined in Table </offsets><xref rid="Tab2" ref-type="table"><offsets xml_i="44349" xml_f="44350" txt_i="28653" txt_f="28654">2</offsets></xref><offsets xml_i="44357" xml_f="44965" txt_i="28654" txt_f="29262">: 1) number of completed calls by the EF with LG providers at each site; 2) number of documented barriers, facilitators, and specific measurable goals to LG uptake; and 3) documentation of LG provider strengths and available opportunities to influence site activities and overcome barriers. Fidelity to the IF role is defined as 1) number of meetings with the LG provider and EF, 2) number of meetings IF and LG provider have with site leadership, 3) number of documented opportunities to leverage LG uptake with existing site priority goals, and 4) development of a strategic plan to implement LG by the IF.</offsets></p></sec><sec id="Sec21"><title><offsets xml_i="44998" xml_f="45027" txt_i="29264" txt_f="29293">Primary outcomes and measures</offsets></title><p><offsets xml_i="45038" xml_f="45440" txt_i="29294" txt_f="29696">Study staff members (not site employees) will collect patient and provider data to ensure consistency of outcomes data collection over time. Outcomes assessors will be blinded to implementation condition. The assessment package previously implemented by study investigators was informed by the RE-AIM framework for evaluating implementation of EBPs and includes measures used in routine clinical care [</offsets><xref ref-type="bibr" rid="CR75"><offsets xml_i="45473" xml_f="45475" txt_i="29696" txt_f="29698">75</offsets></xref><offsets xml_i="45482" xml_f="45485" txt_i="29698" txt_f="29701">],[</offsets><xref ref-type="bibr" rid="CR76"><offsets xml_i="45518" xml_f="45520" txt_i="29701" txt_f="29703">76</offsets></xref><offsets xml_i="45527" xml_f="45644" txt_i="29703" txt_f="29820">]. Key measures include patient-level outcomes, LG fidelity, organizational factors, and REP, EF, and IF activities [</offsets><xref ref-type="bibr" rid="CR49"><offsets xml_i="45677" xml_f="45679" txt_i="29820" txt_f="29822">49</offsets></xref><offsets xml_i="45686" xml_f="45689" txt_i="29822" txt_f="29825">],[</offsets><xref ref-type="bibr" rid="CR77"><offsets xml_i="45722" xml_f="45724" txt_i="29825" txt_f="29827">77</offsets></xref><offsets xml_i="45731" xml_f="45734" txt_i="29827" txt_f="29830">]-[</offsets><xref ref-type="bibr" rid="CR79"><offsets xml_i="45767" xml_f="45769" txt_i="29830" txt_f="29832">79</offsets></xref><offsets xml_i="45776" xml_f="45778" txt_i="29832" txt_f="29834">].</offsets></p></sec><sec id="Sec22"><title><offsets xml_i="45811" xml_f="45834" txt_i="29836" txt_f="29859">Patient data collection</offsets></title><p><offsets xml_i="45845" xml_f="46516" txt_i="29860" txt_f="30531">Lists of patients and contact information that were identified by the LG providers during pre-randomization will be sent to study staff members who will conduct independent clinical assessments. As the study is focused on implementation processes for an evidence-based treatment that does not involve randomizing at the patient level, local institutional review boards (IRBs) considered the protocol to not fall under research, and no patient informed consent is required for the clinical assessments. Staff members will contact patients and describe the purpose of the phone-based clinical assessment, which will be conducted at baseline, 6, 12, 18, and 24 months later.</offsets></p><p><offsets xml_i="46523" xml_f="46646" txt_i="30532" txt_f="30655">The clinical assessment will include previously established measures used in routine care, including the SF-12 for MH-QOL [</offsets><xref ref-type="bibr" rid="CR80"><offsets xml_i="46679" xml_f="46681" txt_i="30655" txt_f="30657">80</offsets></xref><offsets xml_i="46688" xml_f="46769" txt_i="30657" txt_f="30738">] (primary outcome), the Patient Health Questionnaire (PHQ-9) for mood symptoms [</offsets><xref ref-type="bibr" rid="CR81"><offsets xml_i="46802" xml_f="46804" txt_i="30738" txt_f="30740">81</offsets></xref><offsets xml_i="46811" xml_f="46814" txt_i="30740" txt_f="30743">],[</offsets><xref ref-type="bibr" rid="CR82"><offsets xml_i="46847" xml_f="46849" txt_i="30743" txt_f="30745">82</offsets></xref><offsets xml_i="46856" xml_f="46954" txt_i="30745" txt_f="30843">], the World Health Organization Disability Assessment Scale (WHO-DAS) for functional impairment [</offsets><xref ref-type="bibr" rid="CR83"><offsets xml_i="46987" xml_f="46989" txt_i="30843" txt_f="30845">83</offsets></xref><offsets xml_i="46996" xml_f="46999" txt_i="30845" txt_f="30848">],[</offsets><xref ref-type="bibr" rid="CR84"><offsets xml_i="47032" xml_f="47034" txt_i="30848" txt_f="30850">84</offsets></xref><offsets xml_i="47041" xml_f="47072" txt_i="30850" txt_f="30881">], GAD-7 for anxiety symptoms [</offsets><xref ref-type="bibr" rid="CR85"><offsets xml_i="47105" xml_f="47107" txt_i="30881" txt_f="30883">85</offsets></xref><offsets xml_i="47114" xml_f="47166" txt_i="30883" txt_f="30935">], and the Internal State Scale for manic symptoms [</offsets><xref ref-type="bibr" rid="CR86"><offsets xml_i="47199" xml_f="47201" txt_i="30935" txt_f="30937">86</offsets></xref><offsets xml_i="47208" xml_f="47211" txt_i="30937" txt_f="30940">],[</offsets><xref ref-type="bibr" rid="CR87"><offsets xml_i="47244" xml_f="47246" txt_i="30940" txt_f="30942">87</offsets></xref><offsets xml_i="47253" xml_f="47317" txt_i="30942" txt_f="31006">] (secondary and exploratory outcomes). Additional information [</offsets><xref ref-type="bibr" rid="CR44"><offsets xml_i="47350" xml_f="47352" txt_i="31006" txt_f="31008">44</offsets></xref><offsets xml_i="47359" xml_f="47362" txt_i="31008" txt_f="31011">],[</offsets><xref ref-type="bibr" rid="CR88"><offsets xml_i="47395" xml_f="47397" txt_i="31011" txt_f="31013">88</offsets></xref><offsets xml_i="47404" xml_f="47407" txt_i="31013" txt_f="31016">]-[</offsets><xref ref-type="bibr" rid="CR91"><offsets xml_i="47440" xml_f="47442" txt_i="31016" txt_f="31018">91</offsets></xref><offsets xml_i="47449" xml_f="47569" txt_i="31018" txt_f="31138">] including participant demographics will also be ascertained from the clinical assessment during each follow-up period.</offsets></p></sec><sec id="Sec23"><title><offsets xml_i="47602" xml_f="47637" txt_i="31140" txt_f="31175">Provider and organizational surveys</offsets></title><p><offsets xml_i="47648" xml_f="48243" txt_i="31176" txt_f="31771">Study staff members will survey providers from the participating sites, including the site clinical director and LG providers on organizational factors that might impact implementation and outcomes. As the study’s principal institutional review board (University of Michigan Medical School Institutional Review Board - IRBMED) considered this study to fall under quality improvement activities, no informed consent is required from providers or clinic directors. Clinic directors will be contacted prior to the initiation of the REP in-service to complete an initial site organizational survey [</offsets><xref ref-type="bibr" rid="CR43"><offsets xml_i="48276" xml_f="48278" txt_i="31771" txt_f="31773">43</offsets></xref><offsets xml_i="48285" xml_f="48288" txt_i="31773" txt_f="31776">],[</offsets><xref ref-type="bibr" rid="CR44"><offsets xml_i="48321" xml_f="48323" txt_i="31776" txt_f="31778">44</offsets></xref><offsets xml_i="48330" xml_f="48407" txt_i="31778" txt_f="31855">] that includes questions on resources, staff turnover, and integrated care [</offsets><xref ref-type="bibr" rid="CR92"><offsets xml_i="48440" xml_f="48442" txt_i="31855" txt_f="31857">92</offsets></xref><offsets xml_i="48449" xml_f="49105" txt_i="31857" txt_f="32513">]. A longitudinal organizational assessment will also be given to the clinic directors and LG providers prior to the initiation of REP, then again at 12 and 24 months later to assess changes in organizational features that might be impacted by REP and Facilitation. The assessment includes two established questionnaires focused on organizational capacity to implement EBPs. The Implementation Leadership Scale (ILS) assesses the degree of organizational support for EBPs, and the Implementation Climate Scale (ICS) assesses staff’s impressions on expectations and support for effective EBP implementation through their policies, procedure, and behaviors [</offsets><xref ref-type="bibr" rid="CR93"><offsets xml_i="49138" xml_f="49140" txt_i="32513" txt_f="32515">93</offsets></xref><offsets xml_i="49147" xml_f="49149" txt_i="32515" txt_f="32517">].</offsets></p></sec><sec id="Sec24"><title><offsets xml_i="49182" xml_f="49201" txt_i="32519" txt_f="32538">Life goals fidelity</offsets></title><p><offsets xml_i="49212" xml_f="49820" txt_i="32539" txt_f="33147">Because this study is designed to assess real-world implementation, minimally invasive measures to assess LG fidelity will be based on provider logs sent via a secure web-based form to study staff on a weekly basis. Study staff members will also collect confirmatory data from patient surveys on receipt of LG sessions at the patient level. The fidelity monitor calculates a total score based on number of sessions completed by each patient and the percentage completing five of six sessions. Average patient completion of sessions of ≥75% was associated with improved mental health-related quality of life [</offsets><xref ref-type="bibr" rid="CR49"><offsets xml_i="49853" xml_f="49855" txt_i="33147" txt_f="33149">49</offsets></xref><offsets xml_i="49862" xml_f="49864" txt_i="33149" txt_f="33151">].</offsets></p></sec><sec id="Sec25"><title><offsets xml_i="49897" xml_f="49950" txt_i="33153" txt_f="33206">Secondary aims: facilitation implementation and costs</offsets></title><p><offsets xml_i="49961" xml_f="50128" txt_i="33207" txt_f="33374">Data on the implementation of EF and EF/IF will be collected by study staff members using previously established assessments for monitoring implementation activities [</offsets><xref ref-type="bibr" rid="CR40"><offsets xml_i="50161" xml_f="50163" txt_i="33374" txt_f="33376">40</offsets></xref><offsets xml_i="50170" xml_f="50173" txt_i="33376" txt_f="33379">],[</offsets><xref ref-type="bibr" rid="CR43"><offsets xml_i="50206" xml_f="50208" txt_i="33379" txt_f="33381">43</offsets></xref><offsets xml_i="50215" xml_f="50218" txt_i="33381" txt_f="33384">],[</offsets><xref ref-type="bibr" rid="CR94"><offsets xml_i="50251" xml_f="50253" txt_i="33384" txt_f="33386">94</offsets></xref><offsets xml_i="50260" xml_f="50538" txt_i="33386" txt_f="33664">]. Study staff members will interview LG providers, EF, IF, and site clinic leaders regarding barriers and facilitators to LG, REP, and EF/IF strategies, interactions between the EF and IFs, and specific strategies EFs and IFs use to facilitate LG uptake across different sites.</offsets></p><p><offsets xml_i="50545" xml_f="50761" txt_i="33665" txt_f="33881">Implementation strategy costs will be ascertained by the study staff members based on study staff logs of REP activities, and LG provider and EF and IF logs based on a standardized list of activity categories (Table </offsets><xref rid="Tab3" ref-type="table"><offsets xml_i="50795" xml_f="50796" txt_i="33881" txt_f="33882">3</offsets></xref><offsets xml_i="50803" xml_f="51630" txt_i="33882" txt_f="34709">). EF and IF time is likely to account for the vast majority of costs associated with the implementation strategies, including site employees (LG provider time on training and LG implementation, IF time at meetings) as well as project staff (REP package development, training/program assistance, EF Facilitator time in site follow-ups). All costs will be multiplied by personnel wage rates including fringe. Patient-level costs will also be estimated from self-reported utilization survey data on inpatient, ER, and outpatient use. Costs will be assigned using Current Procedural Terminology (CPT) codes, and a relative value unit (RVU) weight will allow us to use the Medicare Fee Schedule to calculate a standardized cost in US dollars for each service, adjusted for annual levels of inflation using the consumer price index.</offsets><table-wrap id="Tab3"><label><offsets xml_i="51659" xml_f="51666" txt_i="34709" txt_f="34716">Table 3</offsets></label><caption><p><offsets xml_i="51686" xml_f="51687" txt_i="34716" txt_f="34717">
</offsets><bold><offsets xml_i="51693" xml_f="51747" txt_i="34717" txt_f="34771">Summary of specific implementation strategy activities</offsets></bold><offsets xml_i="51754" xml_f="51755" txt_i="34771" txt_f="34772">
</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th><offsets xml_i="51821" xml_f="51845" txt_i="34773" txt_f="34797">Implementation component</offsets></th><th><offsets xml_i="51854" xml_f="51859" txt_i="34797" txt_f="34802">Tasks</offsets></th></tr></thead><tbody><tr><td rowspan="14"><offsets xml_i="51905" xml_f="51908" txt_i="34802" txt_f="34805">REP</offsets></td><td><offsets xml_i="51917" xml_f="52011" txt_i="34806" txt_f="34900">Pre-implementation meetings with study staff and consultants to finalize implementation design</offsets></td></tr><tr><td><offsets xml_i="52029" xml_f="52104" txt_i="34901" txt_f="34976">Study staff finalize plans for data security and related research logistics</offsets></td></tr><tr><td><offsets xml_i="52122" xml_f="52201" txt_i="34977" txt_f="35056">Creation of LG website for use by providers (software development, programming)</offsets></td></tr><tr><td><offsets xml_i="52219" xml_f="52293" txt_i="35057" txt_f="35131">Creation of packaged, user-friendly manual and customized training program</offsets></td></tr><tr><td><offsets xml_i="52311" xml_f="52359" txt_i="35132" txt_f="35180">Conduct organizational needs assessment at sites</offsets></td></tr><tr><td><offsets xml_i="52377" xml_f="52433" txt_i="35181" txt_f="35237">Pre-implementation in-service meetings with site leaders</offsets></td></tr><tr><td><offsets xml_i="52451" xml_f="52485" txt_i="35238" txt_f="35272">Identify LG providers at each site</offsets></td></tr><tr><td><offsets xml_i="52503" xml_f="52561" txt_i="35273" txt_f="35331">Identify potential Internal Facilitators (IF) at each site</offsets></td></tr><tr><td><offsets xml_i="52579" xml_f="52604" txt_i="35332" txt_f="35357">Regional 8-h LG trainings</offsets></td></tr><tr><td><offsets xml_i="52622" xml_f="52677" txt_i="35358" txt_f="35413">As-needed program support assistance via phone or email</offsets></td></tr><tr><td><offsets xml_i="52695" xml_f="52743" txt_i="35414" txt_f="35462">Monitor LG uptake via secure web-based reporting</offsets></td></tr><tr><td><offsets xml_i="52761" xml_f="52825" txt_i="35463" txt_f="35527">Disseminate monthly implementation progress reports to all sites</offsets></td></tr><tr><td><offsets xml_i="52843" xml_f="52957" txt_i="35528" txt_f="35642">Sites that are non-responsive are randomized to receive External Facilitation (EF) alone or EF + IF in combination</offsets></td></tr><tr><td><offsets xml_i="52975" xml_f="53098" txt_i="35643" txt_f="35766">Send out quarterly program updates that include bright spots and success stories for overcoming barriers in implementation.</offsets></td></tr><tr><td rowspan="8"><offsets xml_i="53128" xml_f="53154" txt_i="35767" txt_f="35793">External Facilitation (EF)</offsets></td><td><offsets xml_i="53163" xml_f="53279" txt_i="35794" txt_f="35910">Weekly phone calls with facilitators and technical assistance staff to transfer knowledge and strengthen partnership</offsets></td></tr><tr><td><offsets xml_i="53297" xml_f="53421" txt_i="35911" txt_f="36035">EF contacts LG provider/s at non-responsive sites at least monthly for 6 months to develop rapport and understanding of site</offsets></td></tr><tr><td><offsets xml_i="53439" xml_f="53530" txt_i="36036" txt_f="36127">Assist LG providers in identifying what specific actions they can take to implement program</offsets></td></tr><tr><td><offsets xml_i="53548" xml_f="53658" txt_i="36128" txt_f="36238">Works with LG provider to set measurable goals for site implementation and monitors progress to support uptake</offsets></td></tr><tr><td><offsets xml_i="53676" xml_f="53824" txt_i="36239" txt_f="36387">Provides specific guidance on overcoming barriers in implementing LG components by aligning LG’s strengths with LG’s available influence at the site</offsets></td></tr><tr><td><offsets xml_i="53842" xml_f="53950" txt_i="36388" txt_f="36496">Facilitators refer LG providers to existing resources including ongoing LG program assistance when necessary</offsets></td></tr><tr><td><offsets xml_i="53968" xml_f="54057" txt_i="36497" txt_f="36586">Weekly meetings or calls between EF and TA to ensure open communication and collaboration</offsets></td></tr><tr><td><offsets xml_i="54075" xml_f="54140" txt_i="36587" txt_f="36652">Facilitator weekly consultation meeting with facilitation experts</offsets></td></tr><tr><td rowspan="9"><offsets xml_i="54170" xml_f="54196" txt_i="36653" txt_f="36679">Internal Facilitation (IF)</offsets></td><td><offsets xml_i="54205" xml_f="54327" txt_i="36680" txt_f="36802">EF contacts IF at site to provide overview of internal facilitation role and documentation requirements for 6 month period</offsets></td></tr><tr><td><offsets xml_i="54345" xml_f="54475" txt_i="36803" txt_f="36933">IF, EF, and LG hold biweekly calls to develop rapport, review program progress and identify barriers and facilitators to LG uptake</offsets></td></tr><tr><td><offsets xml_i="54493" xml_f="54560" txt_i="36934" txt_f="37001">IF works with LG provider to develop measurable goals to LG uptake.</offsets></td></tr><tr><td><offsets xml_i="54578" xml_f="54656" txt_i="37002" txt_f="37080">IF identifies local site priorities per leadership that align with LG program.</offsets></td></tr><tr><td><offsets xml_i="54674" xml_f="54731" txt_i="37081" txt_f="37138">IF helps LG provider identify other LG program champions.</offsets></td></tr><tr><td><offsets xml_i="54749" xml_f="54918" txt_i="37139" txt_f="37308">EF helps IF and LG provider summarize and describe added value of LG to leadership and site providers (e.g., consistency with other initiatives, support from leadership)</offsets></td></tr><tr><td><offsets xml_i="54936" xml_f="55008" txt_i="37309" txt_f="37381">IF refers LG provider to LG program assistance as needed and appropriate</offsets></td></tr><tr><td><offsets xml_i="55026" xml_f="55094" txt_i="37382" txt_f="37450">IF, EF, and LG provider summarize progress and present to leadership</offsets></td></tr><tr><td><offsets xml_i="55112" xml_f="55216" txt_i="37451" txt_f="37555">IF works with EF and LG provider to develop business and sustainability plans and presents to leadership</offsets></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec26"><title><offsets xml_i="55288" xml_f="55296" txt_i="37558" txt_f="37566">Analyses</offsets></title><p><offsets xml_i="55307" xml_f="55715" txt_i="37567" txt_f="37975">Intent to treat analyses will be performed. The primary analysis will compare interventions in non-responding sites beginning with REP + EF/IF versus interventions beginning with REP + EF on longitudinal patient-level change in number of LG sessions received, SF-12 mental health-related quality of life scores, and PHQ-9 scores. This analysis is a two-sample comparison of cells A + B vs. C + D + E (Figure </offsets><xref rid="Fig2" ref-type="fig"><offsets xml_i="55747" xml_f="55748" txt_i="37975" txt_f="37976">2</offsets></xref><offsets xml_i="55755" xml_f="56052" txt_i="37976" txt_f="38273">). For this analysis, the longitudinal outcomes will be measured at months 6 (pre-randomization), 12, 18, and 24. The primary contrast is the between groups difference in change from month 6 to month 18. The follow-up contrast at month 24 will also be examined in this and all subsequent analyses.</offsets></p><p><offsets xml_i="56059" xml_f="56190" txt_i="38274" txt_f="38405">The primary aim analysis for health-related quality of life (the primary longitudinal outcome) will use linear mixed models (LMM; [</offsets><xref ref-type="bibr" rid="CR95"><offsets xml_i="56223" xml_f="56225" txt_i="38405" txt_f="38407">95</offsets></xref><offsets xml_i="56232" xml_f="57265" txt_i="38407" txt_f="39440">]), also known as random effects models. The unit of analysis is the individual patient within a site (recall that approximately 20 individuals will be identified prior to randomization). LMMs use all available measurements, allowing individuals to have an unequal number of longitudinal observations and producing unbiased parameter estimates as long as unobserved values are missing at random. The analysis will fit a three-level (repeated measures for each individual clustered within site) LMM with fixed effects for the intercept, time, group, and a group-by-time interaction term, where group is an indicator of REP + EF/IF vs. REP + EF. The LMM will include random effects for site and time, an unstructured within-person correlation structure for the residual errors, and it will adjust for state and type of practice (primary care or mental health site). LMMs similar to the above will be conducted for the secondary patient-level outcomes: change in number of LG sessions received, functional impairment, and mood symptoms.</offsets></p><p><offsets xml_i="57272" xml_f="57541" txt_i="39441" txt_f="39710">Secondary aim analyses will be conducted to determine whether continuing REP + EF vs. augmenting with REP + EF/IF leads to changes in outcomes, among sites who are non-responsive to REP + EF at month 12. This secondary analysis is a comparison of cells B vs. C (Figure </offsets><xref rid="Fig2" ref-type="fig"><offsets xml_i="57573" xml_f="57574" txt_i="39710" txt_f="39711">2</offsets></xref><offsets xml_i="57581" xml_f="58115" txt_i="39711" txt_f="40245">). Outcomes will be examined using an LMM similar to that described above, except (a) including only the subset of sites that do not respond at month 12 to REP + EF, (b) using monthly longitudinal outcomes from month 12 to month 24, and (c) the LMM will use dummy indicators for time (i.e., time-saturated model since there are only three measurement times for each longitudinal outcome). The longitudinal course of discontinuing REP + EF (or REP + EF/IF) will also be examined at month 12 among sites that are responsive at month 12.</offsets></p><p><offsets xml_i="58122" xml_f="58265" txt_i="40246" txt_f="40389">Other secondary aim analyses include comparison of EF and EF + IF costs over time using a standardized list of REP and EF/IF activities (Table </offsets><xref rid="Tab3" ref-type="table"><offsets xml_i="58299" xml_f="58300" txt_i="40389" txt_f="40390">3</offsets></xref><offsets xml_i="58307" xml_f="58368" txt_i="40390" txt_f="40451">), as well as assessment of organizational change over time [</offsets><xref ref-type="bibr" rid="CR96"><offsets xml_i="58401" xml_f="58403" txt_i="40451" txt_f="40453">96</offsets></xref><offsets xml_i="58410" xml_f="58537" txt_i="40453" txt_f="40580">]. Additional exploratory analyses will also compare the different adaptive interventions embedded in the SMART design (Figure </offsets><xref rid="Fig2" ref-type="fig"><offsets xml_i="58569" xml_f="58570" txt_i="40580" txt_f="40581">2</offsets></xref><offsets xml_i="58577" xml_f="58670" txt_i="40581" txt_f="40674">) in terms of changes in longitudinal outcomes using methods based on Robins and colleagues [</offsets><xref ref-type="bibr" rid="CR97"><offsets xml_i="58703" xml_f="58705" txt_i="40674" txt_f="40676">97</offsets></xref><offsets xml_i="58712" xml_f="58715" txt_i="40676" txt_f="40679">],[</offsets><xref ref-type="bibr" rid="CR98"><offsets xml_i="58748" xml_f="58750" txt_i="40679" txt_f="40681">98</offsets></xref><offsets xml_i="58757" xml_f="58759" txt_i="40681" txt_f="40683">].</offsets></p><p><offsets xml_i="58766" xml_f="59029" txt_i="40684" txt_f="40947">Missing values may occur in outcomes due to dropout or inability to reach patients for follow-up (anticipated 10% attrition). A thorough investigation of mechanisms for missing data will be carried out and will be dealt with using multiple imputation procedures [</offsets><xref ref-type="bibr" rid="CR99"><offsets xml_i="59062" xml_f="59064" txt_i="40947" txt_f="40949">99</offsets></xref><offsets xml_i="59071" xml_f="59228" txt_i="40949" txt_f="41106">]. In stability analyses, data will be analyzed with and without the multiple imputation strategy. Any discrepancies will be reported and carefully examined.</offsets></p></sec><sec id="Sec27"><title><offsets xml_i="59261" xml_f="59282" txt_i="41108" txt_f="41129">Sample size and power</offsets></title><p><offsets xml_i="59293" xml_f="59549" txt_i="41130" txt_f="41386">The estimated sample size for this study is based on a comparison of between groups (REP + EF/IF versus REP + EF) in changes in the most conservative effect size estimate (mental health-related quality of life scores) between month 6 and month 18 (Cohen’s </offsets><italic><offsets xml_i="59557" xml_f="59558" txt_i="41386" txt_f="41387">D</offsets></italic><offsets xml_i="59567" xml_f="59673" txt_i="41387" txt_f="41493"> = .23). This is a two-sample comparison of patients within sites in cells A + B + C versus D + E (Figure </offsets><xref rid="Fig2" ref-type="fig"><offsets xml_i="59705" xml_f="59706" txt_i="41493" txt_f="41494">2</offsets></xref><offsets xml_i="59713" xml_f="59899" txt_i="41494" txt_f="41680">). To account for the between-site variation induced by the within-site correlation in quality of life outcomes, we inflate the variance term in the standard sample size formula by 1 + (</offsets><italic><offsets xml_i="59907" xml_f="59908" txt_i="41680" txt_f="41681">n</offsets></italic><offsets xml_i="59917" xml_f="60123" txt_i="41681" txt_f="41887"> - 1) × ICC, where ICC is the site inter-class correlation coefficient for the SF-12 mental health-related quality of life component score. Based on our previous randomized controlled implementation trial [</offsets><xref ref-type="bibr" rid="CR40"><offsets xml_i="60156" xml_f="60158" txt_i="41887" txt_f="41889">40</offsets></xref><offsets xml_i="60165" xml_f="60168" txt_i="41889" txt_f="41892">],[</offsets><xref ref-type="bibr" rid="CR43"><offsets xml_i="60201" xml_f="60203" txt_i="41892" txt_f="41894">43</offsets></xref><offsets xml_i="60210" xml_f="60278" txt_i="41894" txt_f="41962">], the site ICC was estimated at .01. Using a two-sided, two-sample </offsets><italic><offsets xml_i="60286" xml_f="60287" txt_i="41962" txt_f="41963">t</offsets></italic><offsets xml_i="60296" xml_f="60790" txt_i="41963" txt_f="42457"> test, a Type I error rate of 5%, and with 60 sites (30 sites randomized to REP + EF/IF versus 30 sites randomized to REP + EF) and 16 patients per site after accounting for attrition, we will have 94% power to detect clinically significant changes in quality of life scores, assuming an ICC = .01. Based on previous data, with SD = 8.35 for the MH-QOL component score, this effect size corresponds to being able to detect a clinically meaningful difference of at least 4 units in MH-QOL score.</offsets></p></sec><sec id="Sec28"><title><offsets xml_i="60823" xml_f="60835" txt_i="42459" txt_f="42471">Trial status</offsets></title><p><offsets xml_i="60846" xml_f="61042" txt_i="42472" txt_f="42668">Sites will be identified and participation confirmed by October 2014. Site training and REP procedures will begin in the fall of 2014. A timeline of implementation activities is provided in Table </offsets><xref rid="Tab3" ref-type="table"><offsets xml_i="61076" xml_f="61077" txt_i="42668" txt_f="42669">3</offsets></xref><offsets xml_i="61084" xml_f="61085" txt_i="42669" txt_f="42670">.</offsets></p></sec></sec><sec id="Sec29"><title><offsets xml_i="61124" xml_f="61134" txt_i="42673" txt_f="42683">Discussion</offsets></title><p><offsets xml_i="61145" xml_f="61823" txt_i="42684" txt_f="43362">To date, this will be one of the largest randomized controlled trials to develop a site-level adaptive implementation strategy. This is also one of the first studies to test the augmentation of an established implementation strategy (REP) using REP + EF/IF or REP + EF alone among sites that exhibit non-response after 6 months. This study will determine whether augmentation of the implementation strategy is needed (e.g., REP + EF/IF) or whether in some circumstances withholding augmentation may result in a delayed implementation effect of REP + EF alone among non-responsive sites. Second, this study will utilize a novel SMART design developed by the study investigators [</offsets><xref ref-type="bibr" rid="CR51"><offsets xml_i="61856" xml_f="61858" txt_i="43362" txt_f="43364">51</offsets></xref><offsets xml_i="61865" xml_f="62292" txt_i="43364" txt_f="43791">] to accomplish this implementation trial. SMARTs allow efficient comparison of the overall impact of receiving different intervention augmentation strategies over time and incremental costs of one intervention strategy over another in improved outcomes among non-responsive sites. In addition, this design allows the potential to determine the added value of implementation strategies applied to real-world treatment settings.</offsets></p><p><offsets xml_i="62299" xml_f="62677" txt_i="43792" txt_f="44170">There is a paucity of research on effective implementation strategy that improves EBP uptake and ultimately patient outcomes, notably in smaller, community-based, safety net practices, which serve a substantial proportion of patients with mood disorders. There have been few rigorous trials of implementation strategy to promote the uptake of EBPs in community-based practices [</offsets><xref ref-type="bibr" rid="CR1"><offsets xml_i="62709" xml_f="62710" txt_i="44170" txt_f="44171">1</offsets></xref><offsets xml_i="62717" xml_f="62720" txt_i="44171" txt_f="44174">],[</offsets><xref ref-type="bibr" rid="CR35"><offsets xml_i="62753" xml_f="62755" txt_i="44174" txt_f="44176">35</offsets></xref><offsets xml_i="62762" xml_f="63067" txt_i="44176" txt_f="44481">]. Previous implementation studies have focused on highly organized practices such as the VA or staff-model HMOs and mainly involved intensive implementation strategy that might not be feasible to apply to smaller, lower-resourced practices. Among the frameworks that guide implementation efforts (e.g., [</offsets><xref ref-type="bibr" rid="CR100"><offsets xml_i="63101" xml_f="63104" txt_i="44481" txt_f="44484">100</offsets></xref><offsets xml_i="63111" xml_f="63216" txt_i="44484" txt_f="44589">]), few have been operationalized sufficiently to enable community-based practices to enhance EBP uptake.</offsets></p><p><offsets xml_i="63223" xml_f="64268" txt_i="44590" txt_f="45635">Adaptive Implementation of Effective Programs Trial (ADEPT) represents a growing cadre of rigorous yet real-world trials that involve site-level randomization of quality improvement strategies to augment the implementation of evidence-based practices. Specifically, informed consent from participants is not required per the recommendation of the IRB because the focus of ADEPT is on the use of implementation strategies at the site level, above and beyond available resources to disseminate effective programs, in order to assist existing providers in adopting an evidence-based practice. Moreover, the delivery of the evidence-based practice to patients is not altered or controlled at the sites by the study team, and patient clinical assessment includes measures that are used across many of the practice settings as part of routine clinical care. These types of studies have high generalizability to real-world settings because they reflect the pragmatic strategies needed to improve healthcare delivery and foster learning health systems [</offsets><xref ref-type="bibr" rid="CR101"><offsets xml_i="64302" xml_f="64305" txt_i="45635" txt_f="45638">101</offsets></xref><offsets xml_i="64312" xml_f="64315" txt_i="45638" txt_f="45641">],[</offsets><xref ref-type="bibr" rid="CR102"><offsets xml_i="64349" xml_f="64352" txt_i="45641" txt_f="45644">102</offsets></xref><offsets xml_i="64359" xml_f="64668" txt_i="45644" txt_f="45953">]. ADEPT evaluates the use of an evidence-based intervention (i.e., life goals) that is superior to usual care from the patient perspective while testing an implementation strategy (facilitation) that is beneficial to providers and practices by improving their ability to adopt such evidence-based practices [</offsets><xref ref-type="bibr" rid="CR102"><offsets xml_i="64702" xml_f="64705" txt_i="45953" txt_f="45956">102</offsets></xref><offsets xml_i="64712" xml_f="65089" txt_i="45956" txt_f="46333">]. Designation as a QI trial does not remove IRB regulatory oversight but instead reduces the burden on researchers (costs) and patients (time) to participate in written informed consent and formal survey assessment meetings which do not reflect real-world care but instead introduce potential patient selection biases that undermine patient participation in the intervention [</offsets><xref ref-type="bibr" rid="CR101"><offsets xml_i="65123" xml_f="65126" txt_i="46333" txt_f="46336">101</offsets></xref><offsets xml_i="65133" xml_f="65136" txt_i="46336" txt_f="46339">],[</offsets><xref ref-type="bibr" rid="CR102"><offsets xml_i="65170" xml_f="65173" txt_i="46339" txt_f="46342">102</offsets></xref><offsets xml_i="65180" xml_f="65182" txt_i="46342" txt_f="46344">].</offsets></p><p><xref ref-type="bibr" rid="CR10"><offsets xml_i="65222" xml_f="65224" txt_i="46345" txt_f="46347">10</offsets></xref><offsets xml_i="65231" xml_f="65234" txt_i="46347" txt_f="46350">],[</offsets><xref ref-type="bibr" rid="CR15"><offsets xml_i="65267" xml_f="65269" txt_i="46350" txt_f="46352">15</offsets></xref><offsets xml_i="65276" xml_f="65279" txt_i="46352" txt_f="46355">],[</offsets><xref ref-type="bibr" rid="CR16"><offsets xml_i="65312" xml_f="65314" txt_i="46355" txt_f="46357">16</offsets></xref><offsets xml_i="65321" xml_f="65324" txt_i="46357" txt_f="46360">],[</offsets><xref ref-type="bibr" rid="CR103"><offsets xml_i="65358" xml_f="65361" txt_i="46360" txt_f="46363">103</offsets></xref><offsets xml_i="65368" xml_f="65469" txt_i="46363" txt_f="46464">]. Addressing these barriers may require strategic thinking and multilevel organizational alliances [</offsets><xref ref-type="bibr" rid="CR104"><offsets xml_i="65503" xml_f="65506" txt_i="46464" txt_f="46467">104</offsets></xref><offsets xml_i="65513" xml_f="65516" txt_i="46467" txt_f="46470">],[</offsets><xref ref-type="bibr" rid="CR105"><offsets xml_i="65550" xml_f="65553" txt_i="46470" txt_f="46473">105</offsets></xref><offsets xml_i="65560" xml_f="65629" txt_i="46473" txt_f="46542">] that engage providers in supporting and owning the implementation [</offsets><xref ref-type="bibr" rid="CR106"><offsets xml_i="65663" xml_f="65666" txt_i="46542" txt_f="46545">106</offsets></xref><offsets xml_i="65673" xml_f="65676" txt_i="46545" txt_f="46548">]-[</offsets><xref ref-type="bibr" rid="CR108"><offsets xml_i="65710" xml_f="65713" txt_i="46548" txt_f="46551">108</offsets></xref><offsets xml_i="65720" xml_f="65778" txt_i="46551" txt_f="46609">]. While leadership support in EBP adoption is important [</offsets><xref ref-type="bibr" rid="CR109"><offsets xml_i="65812" xml_f="65815" txt_i="46609" txt_f="46612">109</offsets></xref><offsets xml_i="65822" xml_f="65825" txt_i="46612" txt_f="46615">]-[</offsets><xref ref-type="bibr" rid="CR111"><offsets xml_i="65859" xml_f="65862" txt_i="46615" txt_f="46618">111</offsets></xref><offsets xml_i="65869" xml_f="65960" txt_i="46618" txt_f="46709">], involvement and buy-in from frontline providers are also crucial to EBP sustainability [</offsets><xref ref-type="bibr" rid="CR94"><offsets xml_i="65993" xml_f="65995" txt_i="46709" txt_f="46711">94</offsets></xref><offsets xml_i="66002" xml_f="66005" txt_i="46711" txt_f="46714">],[</offsets><xref ref-type="bibr" rid="CR109"><offsets xml_i="66039" xml_f="66042" txt_i="46714" txt_f="46717">109</offsets></xref><offsets xml_i="66049" xml_f="66052" txt_i="46717" txt_f="46720">],[</offsets><xref ref-type="bibr" rid="CR112"><offsets xml_i="66086" xml_f="66089" txt_i="46720" txt_f="46723">112</offsets></xref><offsets xml_i="66096" xml_f="66099" txt_i="46723" txt_f="46726">]-[</offsets><xref ref-type="bibr" rid="CR118"><offsets xml_i="66133" xml_f="66136" txt_i="46726" txt_f="46729">118</offsets></xref><offsets xml_i="66143" xml_f="66236" txt_i="46729" txt_f="46822">]. Hence, REP may need to be augmented to address these organizational barriers to adoption [</offsets><xref ref-type="bibr" rid="CR119"><offsets xml_i="66270" xml_f="66273" txt_i="46822" txt_f="46825">119</offsets></xref><offsets xml_i="66280" xml_f="66283" txt_i="46825" txt_f="46828">],[</offsets><xref ref-type="bibr" rid="CR120"><offsets xml_i="66317" xml_f="66320" txt_i="46828" txt_f="46831">120</offsets></xref><offsets xml_i="66327" xml_f="66450" txt_i="46831" txt_f="46954">] and to ultimately show value of the EBP through the triple aim (improving patient outcomes, experience, lowering costs) [</offsets><xref ref-type="bibr" rid="CR121"><offsets xml_i="66484" xml_f="66487" txt_i="46954" txt_f="46957">121</offsets></xref><offsets xml_i="66494" xml_f="66496" txt_i="46957" txt_f="46959">].</offsets></p><p><offsets xml_i="66503" xml_f="67274" txt_i="46960" txt_f="47731">Our study will determine the added value of augmenting implementation programs through Facilitation on EBP uptake, sustainability, and patient outcomes, ultimately determining the public health impact of implementation strategies for persons with mental disorders. Akin to stepped treatment for patients, adaptive SMART designs provide a tailored and potentially cost-effective approach to augmenting standard implementation programs based on the specific needs of a site. This approach is needed to better understand how to improve EBP uptake and patient mental health outcomes using Facilitation, whereby REP is augmented given early signs of site non-response. While REP might be sufficient for some sites in adopting EBPs, our preliminary studies and prior research [</offsets><xref ref-type="bibr" rid="CR122"><offsets xml_i="67308" xml_f="67311" txt_i="47731" txt_f="47734">122</offsets></xref><offsets xml_i="67318" xml_f="67321" txt_i="47734" txt_f="47737">],[</offsets><xref ref-type="bibr" rid="CR123"><offsets xml_i="67355" xml_f="67358" txt_i="47737" txt_f="47740">123</offsets></xref><offsets xml_i="67365" xml_f="67747" txt_i="47740" txt_f="48122">] suggest that the majority will need additional assistance. Moreover, sites initially not responding to REP (i.e., limited adoption of EBPs) were unlikely to do so in the future. IF is more expensive for sites to implement, as the additional customization and relationship building across individual sites due to variations in culture, climate, and capacity can be time consuming [</offsets><xref ref-type="bibr" rid="CR113"><offsets xml_i="67781" xml_f="67784" txt_i="48122" txt_f="48125">113</offsets></xref><offsets xml_i="67791" xml_f="67868" txt_i="48125" txt_f="48202">]. It is also unclear how long Facilitation is needed to achieve its effect [</offsets><xref ref-type="bibr" rid="CR103"><offsets xml_i="67902" xml_f="67905" txt_i="48202" txt_f="48205">103</offsets></xref><offsets xml_i="67912" xml_f="67915" txt_i="48205" txt_f="48208">],[</offsets><xref ref-type="bibr" rid="CR109"><offsets xml_i="67949" xml_f="67952" txt_i="48208" txt_f="48211">109</offsets></xref><offsets xml_i="67959" xml_f="67962" txt_i="48211" txt_f="48214">],[</offsets><xref ref-type="bibr" rid="CR117"><offsets xml_i="67996" xml_f="67999" txt_i="48214" txt_f="48217">117</offsets></xref><offsets xml_i="68006" xml_f="68275" txt_i="48217" txt_f="48486">]. Adaptive interventions involving REP and augmentation through Facilitation are needed to determine the added value of REP + EF/IF on improved patient outcomes, how long Facilitation need to be continued to achieve outcomes, and the cost-effectiveness of REP + EF/IF.</offsets></p><p><offsets xml_i="68282" xml_f="69791" txt_i="48487" txt_f="49996">While this study has a number of strengths, including the use of a novel implementation study design within community-based practices, there are key limitations that need to be considered. First, there is the potential for self-selection of site early adopters which can limit generalizability. The involvement of sites most willing to participate in studies is inevitable with any implementation design. We have mitigated this potential selection effect by inviting all sites from networks of practices through state associations from across the country. In addition, LG uptake and fidelity measures do not include direct observations of sessions. In order to conduct an implementation trial that reflected real-world considerations, we chose to use indirect methods to measure LG uptake, and cost considerations precluded us from conducting in-person observations. Nonetheless, because the study was considered non-regulated (non-research), there is potential for increased generalizability especially if patient dropout is minimized because they will be assessed as part of routine clinical care. In addition, there is a chance for contamination between the EF and IF implementation strategies, especially if a less engaged IF might promote the EF to become more active in assisting the LG provider in identifying barriers and facilitators to program uptake. Finally, not all sites from each state participated, and those what are enrolled may not be representative of community-based practices nationwide.</offsets></p></sec><sec id="Sec30"><title><offsets xml_i="69824" xml_f="69835" txt_i="49998" txt_f="50009">Conclusions</offsets></title><p><offsets xml_i="69846" xml_f="70572" txt_i="50010" txt_f="50736">The results of this study will inform the implementation of evidence-based practices across sites in two states, as well as how to conduct practical implementation studies in real-world healthcare settings. This study also sets the stage for determining the added value of more intensive implementation strategies within sites that need additional support to promote the uptake of EBPs. Ultimately, adaptive implementation strategies may produce more relevant, rapid, and generalizable results by more quickly validating or rejecting new implementation strategies, thus enhancing the efficiency and sustainability of implementation research and potentially lead to the rollout of more cost-efficient implementation strategies.</offsets></p></sec><sec id="Sec31"><title><offsets xml_i="70605" xml_f="70627" txt_i="50738" txt_f="50760">Authors’ contributions</offsets></title><p><offsets xml_i="70638" xml_f="71337" txt_i="50761" txt_f="51460">AMK provided funding for the study, developed the implementation methods, and drafted the manuscript. DA, DE, MSB, and JCF provided input on the study design and feedback on paper drafts. DEG, MRT, JEK, LIS, and JW provided literature and relevant background on the implementation model, as well as critically reviewed subsequent drafts. MSB, LIS, DE, and JK provided input on the adaptation of the clinical program and outcomes assessment design. KMN, JEK, JK, SAM, and JW operationalized the adaptive interventions and reviewed paper drafts. KMN, DM, JF, SM, and JK reviewed the study drafts and provided components of the clinical intervention. All authors read and approved the final manuscript.</offsets></p></sec></body><back><app-group><app id="App1"><sec id="Sec32"><title>Authors’ original submitted files for images</title><p>Below are the links to the authors’ original submitted files for images.<media position="anchor" xlink:href="13012_2014_132_MOESM1_ESM.gif" id="MOESM1"><caption><p>Authors’ original file for figure 1</p></caption></media><media position="anchor" xlink:href="13012_2014_132_MOESM2_ESM.gif" id="MOESM2"><caption><p>Authors’ original file for figure 2</p></caption></media></p></sec></app></app-group><fn-group><fn><p><bold>Competing interests</bold></p><p>The authors declare that they have no competing interests.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This research was supported by the National Institute of Mental Health (R01 099898). The views expressed in this article are those of the authors and do not necessarily represent the views of the VA.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proctor</surname><given-names>E</given-names></name><name><surname>Landsverk</surname><given-names>J</given-names></name><name><surname>Aarons</surname><given-names>G</given-names></name><name><surname>Chambers</surname><given-names>D</given-names></name><name><surname>Glisson</surname><given-names>C</given-names></name><name><surname>Mittman</surname><given-names>B</given-names></name></person-group><article-title>Implementation research in mental health services: an emerging science with conceptual, methodological, and training challenges</article-title><source>Adm Policy Ment Health</source><year>2009</year><volume>36</volume><fpage>24</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1007/s10488-008-0197-4</pub-id><pub-id pub-id-type="pmid">19104929</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>CJ</given-names></name><name><surname>Lopez</surname><given-names>AD</given-names></name></person-group><article-title>Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study</article-title><source>Lancet</source><year>1997</year><volume>349</volume><fpage>1436</fpage><lpage>1442</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(96)07495-8</pub-id><pub-id pub-id-type="pmid">9164317</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">The Impact of Mental Illness on Society, NIH Report No. 01 4586. 2001, National Institutes of Health, Bethesda</mixed-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yatham</surname><given-names>LN</given-names></name><name><surname>Kennedy</surname><given-names>SH</given-names></name><name><surname>Schaffer</surname><given-names>A</given-names></name><name><surname>Parikh</surname><given-names>SV</given-names></name><name><surname>Beaulieu</surname><given-names>S</given-names></name><name><surname>O'Donovan</surname><given-names>C</given-names></name><name><surname>MacQueen</surname><given-names>G</given-names></name><name><surname>McIntyre</surname><given-names>RS</given-names></name><name><surname>Sharma</surname><given-names>V</given-names></name><name><surname>Ravindran</surname><given-names>A</given-names></name><name><surname>Young</surname><given-names>LT</given-names></name><name><surname>Young</surname><given-names>AH</given-names></name><name><surname>Alda</surname><given-names>M</given-names></name><name><surname>Miley</surname><given-names>R</given-names></name><name><surname>Vieta</surname><given-names>E</given-names></name><name><surname>Calabrese</surname><given-names>JR</given-names></name><name><surname>Berk</surname><given-names>M</given-names></name><name><surname>Ha</surname><given-names>K</given-names></name><name><surname>Kapczinski</surname><given-names>F</given-names></name></person-group><article-title>Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009</article-title><source>Bipolar Disord</source><year>2009</year><volume>11</volume><fpage>225</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1111/j.1399-5618.2009.00672.x</pub-id><pub-id pub-id-type="pmid">19419382</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>MS</given-names></name><name><surname>Callahan</surname><given-names>AM</given-names></name><name><surname>Jampala</surname><given-names>C</given-names></name><name><surname>Petty</surname><given-names>F</given-names></name><name><surname>Sajatovic</surname><given-names>M</given-names></name><name><surname>Schaefer</surname><given-names>V</given-names></name><name><surname>Wittlin</surname><given-names>B</given-names></name><name><surname>Powell</surname><given-names>BJ</given-names></name></person-group><article-title>Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs</article-title><source>J Clin Psychiatry</source><year>1999</year><volume>60</volume><fpage>9</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.4088/JCP.v60n0104</pub-id><pub-id pub-id-type="pmid">10074872</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">Practice Guideline for the Treatment of Patients with Major Depressive Disorder. 2010, American Psychiatric Association (APA), Arlington</mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002, 159: 1-50.</mixed-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy-Byrne</surname><given-names>PP</given-names></name><name><surname>Sherbourne</surname><given-names>CD</given-names></name><name><surname>Craske</surname><given-names>MG</given-names></name><name><surname>Stein</surname><given-names>MB</given-names></name><name><surname>Katon</surname><given-names>W</given-names></name><name><surname>Sullivan</surname><given-names>G</given-names></name><name><surname>Means-Christensen</surname><given-names>A</given-names></name><name><surname>Bystritsky</surname><given-names>A</given-names></name></person-group><article-title>Moving treatment research from clinical trials to the real world</article-title><source>Psychiatr Serv</source><year>2003</year><volume>54</volume><fpage>327</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1176/appi.ps.54.3.327</pub-id><pub-id pub-id-type="pmid">12610239</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>KB</given-names></name><name><surname>Miranda</surname><given-names>J</given-names></name><name><surname>Gonzalez</surname><given-names>JJ</given-names></name></person-group><article-title>Overcoming barriers and creating opportunities to reduce burden of affective disorders: a new research agenda</article-title><source>Ment Health Serv Res</source><year>2002</year><volume>4</volume><fpage>175</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1023/A:1020947829820</pub-id><pub-id pub-id-type="pmid">12558001</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horvitz-Lennon</surname><given-names>M</given-names></name><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Pincus</surname><given-names>HA</given-names></name></person-group><article-title>From silos to bridges: meeting the general health care needs of adults with severe mental illnesses</article-title><source>Health Aff (Millwood)</source><year>2006</year><volume>25</volume><fpage>659</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1377/hlthaff.25.3.659</pub-id><pub-id pub-id-type="pmid">16684729</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>RC</given-names></name><name><surname>Berglund</surname><given-names>P</given-names></name><name><surname>Demler</surname><given-names>O</given-names></name><name><surname>Jin</surname><given-names>R</given-names></name><name><surname>Koretz</surname><given-names>D</given-names></name><name><surname>Merikangas</surname><given-names>KR</given-names></name><name><surname>Rush</surname><given-names>AJ</given-names></name><name><surname>Walters</surname><given-names>EE</given-names></name><name><surname>Wang</surname><given-names>PS</given-names></name></person-group><article-title>The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)</article-title><source>JAMA</source><year>2003</year><volume>289</volume><fpage>3095</fpage><lpage>3105</lpage><pub-id pub-id-type="doi">10.1001/jama.289.23.3095</pub-id><pub-id pub-id-type="pmid">12813115</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Schulberg</surname><given-names>HC</given-names></name><name><surname>Post</surname><given-names>EP</given-names></name><name><surname>Rollman</surname><given-names>BL</given-names></name><name><surname>Belnap</surname><given-names>BH</given-names></name><name><surname>Pincus</surname><given-names>HA</given-names></name></person-group><article-title>Translating evidence-based depression management services to community-based primary care practices</article-title><source>Milbank Q</source><year>2004</year><volume>82</volume><fpage>631</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1111/j.0887-378X.2004.00326.x</pub-id><pub-id pub-id-type="pmid">15595945</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>G</given-names></name><name><surname>Duan</surname><given-names>N</given-names></name><name><surname>Kirchner</surname><given-names>J</given-names></name><name><surname>Henderson</surname><given-names>KL</given-names></name></person-group><article-title>Reinventing evidence-based interventions?</article-title><source>Psychiatr Serv</source><year>2005</year><volume>56</volume><fpage>1156</fpage><lpage>1157</lpage><pub-id pub-id-type="doi">10.1176/appi.ps.56.9.1156-a</pub-id><pub-id pub-id-type="pmid">16148337</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>K</given-names></name><name><surname>Miranda</surname><given-names>J</given-names></name><name><surname>Bruce</surname><given-names>ML</given-names></name><name><surname>Alegria</surname><given-names>M</given-names></name><name><surname>Wallerstein</surname><given-names>N</given-names></name></person-group><article-title>Bridging community intervention and mental health services research</article-title><source>Am J Psychiatry</source><year>2004</year><volume>161</volume><fpage>955</fpage><lpage>963</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.161.6.955</pub-id><pub-id pub-id-type="pmid">15169681</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hovmand</surname><given-names>PS</given-names></name><name><surname>Gillespie</surname><given-names>DF</given-names></name></person-group><article-title>Implementation of evidence-based practice and organizational performance</article-title><source>J Behav Health Serv Res</source><year>2010</year><volume>37</volume><fpage>79</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1007/s11414-008-9154-y</pub-id><pub-id pub-id-type="pmid">19085109</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swain</surname><given-names>K</given-names></name><name><surname>Whitley</surname><given-names>R</given-names></name><name><surname>McHugo</surname><given-names>GJ</given-names></name><name><surname>Drake</surname><given-names>RE</given-names></name></person-group><article-title>The sustainability of evidence-based practices in routine mental health agencies</article-title><source>Community Ment Health J</source><year>2010</year><volume>46</volume><fpage>119</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1007/s10597-009-9202-y</pub-id><pub-id pub-id-type="pmid">19544094</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Steckler</surname><given-names>A</given-names></name><name><surname>Goodman</surname><given-names>RM</given-names></name><name><surname>Kegler</surname><given-names>MC</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Glanz</surname><given-names>K</given-names></name><name><surname>Rimmer</surname><given-names>BK</given-names></name><name><surname>Lewis</surname><given-names>FM</given-names></name></person-group><article-title>Mobilizing organizations for health enhancement: theories of organizational change</article-title><source>Health Behavior and Health Education: Theory, Research and Practice</source><year>2002</year><edition>3</edition><publisher-loc>San Francisco</publisher-loc><publisher-name>Jossey-Bass</publisher-name><fpage>335</fpage><lpage>360</lpage></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glisson</surname><given-names>C</given-names></name><name><surname>Green</surname><given-names>P</given-names></name></person-group><article-title>The effects of organizational culture and climate on the access to mental health care in child welfare and juvenile justice systems</article-title><source>Adm Policy Ment Health</source><year>2006</year><volume>33</volume><fpage>433</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1007/s10488-005-0016-0</pub-id><pub-id pub-id-type="pmid">16240076</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aarons</surname><given-names>GA</given-names></name><name><surname>Sawitzky</surname><given-names>AC</given-names></name></person-group><article-title>Organizational climate partially mediates the effect of culture on work attitudes and staff turnover in mental health services</article-title><source>Adm Policy Ment Health</source><year>2006</year><volume>33</volume><fpage>289</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1007/s10488-006-0039-1</pub-id><pub-id pub-id-type="pmid">16544205</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glisson</surname><given-names>C</given-names></name></person-group><article-title>The organizational context of children's mental health services</article-title><source>Clin Child Fam Psych</source><year>2002</year><volume>5</volume><fpage>233</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1023/A:1020972906177</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glisson</surname><given-names>C</given-names></name><name><surname>James</surname><given-names>LR</given-names></name></person-group><article-title>The cross-level effects of culture and climate in human services teams</article-title><source>J Organ Behav</source><year>2002</year><volume>23</volume><fpage>767</fpage><lpage>794</lpage><pub-id pub-id-type="doi">10.1002/job.162</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Greenwald</surname><given-names>DE</given-names></name><name><surname>Hermann</surname><given-names>RC</given-names></name><name><surname>Charns</surname><given-names>MP</given-names></name><name><surname>McCarthy</surname><given-names>JF</given-names></name><name><surname>Yano</surname><given-names>EM</given-names></name></person-group><article-title>Financial incentives and accountability for integrated medical care in Department of Veterans Affairs mental health programs</article-title><source>Psychiatr Serv</source><year>2010</year><volume>61</volume><fpage>38</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1176/ps.2010.61.1.38</pub-id><pub-id pub-id-type="pmid">20044416</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schutte</surname><given-names>K</given-names></name><name><surname>Yano</surname><given-names>EM</given-names></name><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Wickrama</surname><given-names>B</given-names></name><name><surname>Kirchner</surname><given-names>JE</given-names></name><name><surname>Humphreys</surname><given-names>K</given-names></name></person-group><article-title>Organizational contexts of primary care approaches for managing problem drinking</article-title><source>J Subst Abuse Treat</source><year>2009</year><volume>36</volume><fpage>435</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1016/j.jsat.2008.09.002</pub-id><pub-id pub-id-type="pmid">19004595</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Pincus</surname><given-names>HA</given-names></name><name><surname>Schutte</surname><given-names>K</given-names></name><name><surname>Kirchner</surname><given-names>JE</given-names></name><name><surname>Haas</surname><given-names>GL</given-names></name><name><surname>Yano</surname><given-names>EM</given-names></name></person-group><article-title>Management of mental disorders in VA primary care practices</article-title><source>Adm Policy Ment Health</source><year>2006</year><volume>33</volume><fpage>208</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1007/s10488-006-0034-6</pub-id><pub-id pub-id-type="pmid">16477518</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Insel</surname><given-names>TR</given-names></name></person-group><article-title>Translating scientific opportunity into public health impact: a strategic plan for research on mental illness</article-title><source>Arch Gen Psychiatry</source><year>2009</year><volume>66</volume><fpage>128</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2008.540</pub-id><pub-id pub-id-type="pmid">19188534</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">Crossing the Quality Chasm: A New Health System for the 21st Century. 2003, National Academy Press, Washington, D.C</mixed-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>ES</given-names></name><name><surname>McClellan</surname><given-names>MB</given-names></name><name><surname>Bertko</surname><given-names>J</given-names></name><name><surname>Lieberman</surname><given-names>SM</given-names></name><name><surname>Lee</surname><given-names>JJ</given-names></name><name><surname>Lewis</surname><given-names>JL</given-names></name><name><surname>Skinner</surname><given-names>JS</given-names></name></person-group><article-title>Fostering accountable health care: moving forward in medicare</article-title><source>Health Aff (Millwood)</source><year>2009</year><volume>28</volume><fpage>w219</fpage><lpage>w231</lpage><pub-id pub-id-type="doi">10.1377/hlthaff.28.2.w219</pub-id><pub-id pub-id-type="pmid">19174383</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>ES</given-names></name></person-group><article-title>Building a medical neighborhood for the medical home</article-title><source>N Engl J Med</source><year>2008</year><volume>359</volume><fpage>1202</fpage><lpage>1205</lpage><pub-id pub-id-type="doi">10.1056/NEJMp0806233</pub-id><pub-id pub-id-type="pmid">18799556</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClellan</surname><given-names>M</given-names></name><name><surname>McKethan</surname><given-names>AN</given-names></name><name><surname>Lewis</surname><given-names>JL</given-names></name><name><surname>Roski</surname><given-names>J</given-names></name><name><surname>Fisher</surname><given-names>ES</given-names></name></person-group><article-title>A national strategy to put accountable care into practice</article-title><source>Health Aff (Millwood)</source><year>2010</year><volume>29</volume><fpage>982</fpage><lpage>990</lpage><pub-id pub-id-type="doi">10.1377/hlthaff.2010.0194</pub-id><pub-id pub-id-type="pmid">20439895</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>MS</given-names></name><name><surname>Leader</surname><given-names>D</given-names></name><name><surname>Un</surname><given-names>H</given-names></name><name><surname>Lai</surname><given-names>Z</given-names></name><name><surname>Kilbourne</surname><given-names>AM</given-names></name></person-group><article-title>Primary care and behavioral health practice size: the challenge for health care reform</article-title><source>Med Care</source><year>2012</year><volume>50</volume><fpage>843</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1097/MLR.0b013e31825f2864</pub-id><pub-id pub-id-type="pmid">22814854</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berwick</surname><given-names>DM</given-names></name></person-group><article-title>Disseminating innovations in health care</article-title><source>JAMA</source><year>2003</year><volume>289</volume><fpage>1969</fpage><lpage>1975</lpage><pub-id pub-id-type="doi">10.1001/jama.289.15.1969</pub-id><pub-id pub-id-type="pmid">12697800</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>N</given-names></name><name><surname>Braslow</surname><given-names>JT</given-names></name><name><surname>Weisz</surname><given-names>JR</given-names></name><name><surname>Wells</surname><given-names>KB</given-names></name></person-group><article-title>Fidelity, adherence, and robustness of interventions</article-title><source>Psychiatr Serv</source><year>2001</year><volume>52</volume><fpage>413</fpage><pub-id pub-id-type="doi">10.1176/appi.ps.52.4.413</pub-id><pub-id pub-id-type="pmid">11274482</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>D</given-names></name><name><surname>McDaniel</surname><given-names>RR</given-names><suffix>Jr</suffix></name><name><surname>Crabtree</surname><given-names>BF</given-names></name><name><surname>Ruhe</surname><given-names>MC</given-names></name><name><surname>Weyer</surname><given-names>SM</given-names></name><name><surname>Tallia</surname><given-names>A</given-names></name><name><surname>Miller</surname><given-names>WL</given-names></name><name><surname>Goodwin</surname><given-names>MA</given-names></name><name><surname>Nutting</surname><given-names>P</given-names></name><name><surname>Solberg</surname><given-names>LI</given-names></name><name><surname>Zyzanski</surname><given-names>SJ</given-names></name><name><surname>Jaen</surname><given-names>CR</given-names></name><name><surname>Gilchrist</surname><given-names>V</given-names></name><name><surname>Stange</surname><given-names>KC</given-names></name></person-group><article-title>A practice change model for quality improvement in primary care practice</article-title><source>J Healthc Manag</source><year>2004</year><volume>49</volume><fpage>155</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">15190858</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sales</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>J</given-names></name><name><surname>Curran</surname><given-names>G</given-names></name><name><surname>Kochevar</surname><given-names>L</given-names></name></person-group><article-title>Models, strategies, and tools: theory in implementing evidence-based findings into health care practice</article-title><source>J Gen Intern Med</source><year>2006</year><volume>21</volume><issue>Suppl 2</issue><fpage>S43</fpage><lpage>S49</lpage><pub-id pub-id-type="pmid">16637960</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Neumann</surname><given-names>MS</given-names></name><name><surname>Pincus</surname><given-names>HA</given-names></name><name><surname>Bauer</surname><given-names>MS</given-names></name><name><surname>Stall</surname><given-names>R</given-names></name></person-group><article-title>Implementing evidence-based interventions in health care: application of the replicating effective programs framework</article-title><source>Implement Sci</source><year>2007</year><volume>2</volume><fpage>42</fpage><pub-id pub-id-type="doi">10.1186/1748-5908-2-42</pub-id><pub-id pub-id-type="pmid">18067681</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>E</given-names></name></person-group><source>Diffusion of Innovations</source><year>2003</year><publisher-loc>New York</publisher-loc><publisher-name>Free Press</publisher-name></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Green</surname><given-names>LW</given-names></name><name><surname>Kreuter</surname><given-names>MW</given-names></name></person-group><source>Health Promotion Planning: An Educational and Environmental Approach</source><year>1991</year><publisher-loc>Mountain View</publisher-loc><publisher-name>Mayfield Publishing Co.</publisher-name></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tax</surname><given-names>S</given-names></name></person-group><article-title>The Fox Project</article-title><source>Hum Organ</source><year>1958</year><volume>17</volume><fpage>17</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.17730/humo.17.1.b1gtr520r323687t</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandura</surname><given-names>A</given-names></name></person-group><article-title>Self-efficacy: toward a unifying theory of behavioral change</article-title><source>Psychol Rev</source><year>1977</year><volume>84</volume><fpage>191</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1037/0033-295X.84.2.191</pub-id><pub-id pub-id-type="pmid">847061</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Abraham</surname><given-names>KM</given-names></name><name><surname>Goodrich</surname><given-names>DE</given-names></name><name><surname>Bowersox</surname><given-names>NW</given-names></name><name><surname>Almirall</surname><given-names>D</given-names></name><name><surname>Lai</surname><given-names>Z</given-names></name><name><surname>Nord</surname><given-names>KM</given-names></name></person-group><article-title>Cluster randomized adaptive implementation trial comparing a standard versus enhanced implementation intervention to improve uptake of an effective re-engagement program for patients with serious mental illness</article-title><source>Implement Sci</source><year>2013</year><volume>8</volume><fpage>136</fpage><pub-id pub-id-type="doi">10.1186/1748-5908-8-136</pub-id><pub-id pub-id-type="pmid">24252648</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirchner</surname><given-names>JE</given-names></name><name><surname>Kearney</surname><given-names>LK</given-names></name><name><surname>Ritchie</surname><given-names>MJ</given-names></name><name><surname>Dollar</surname><given-names>KM</given-names></name><name><surname>Swensen</surname><given-names>AB</given-names></name><name><surname>Schohn</surname><given-names>M</given-names></name></person-group><article-title>Research &amp; services partnerships: lessons learned through a national partnership between clinical leaders and researchers</article-title><source>Psychiatr Serv</source><year>2014</year><volume>65</volume><issue>5</issue><fpage>577</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1176/appi.ps.201400054</pub-id><pub-id pub-id-type="pmid">24585229</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="other">Kilbourne AM, Goodrich DE, Lai Z, Almirall D, Nord KM, Bowersox NW, Abraham KA: Re-engaging veterans with serious mental illness into care: preliminary results from a national randomized trial of an enhanced versus standard implementation strategy.<italic>Psychiatr Serv</italic> 2014, in press.,</mixed-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waxmonsky</surname><given-names>J</given-names></name><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Goodrich</surname><given-names>DE</given-names></name><name><surname>Nord</surname><given-names>KM</given-names></name><name><surname>Lai</surname><given-names>Z</given-names></name><name><surname>Laird</surname><given-names>C</given-names></name><name><surname>Clogston</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>HM</given-names></name><name><surname>Miller</surname><given-names>C</given-names></name><name><surname>Bauer</surname><given-names>MS</given-names></name></person-group><article-title>Enhanced fidelity to treatment for bipolar disorder: results from a randomized controlled implementation trial</article-title><source>Psychiatr Serv</source><year>2014</year><volume>65</volume><issue>1</issue><fpage>81</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1176/appi.ps.201300039</pub-id><pub-id pub-id-type="pmid">24129806</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="other">Kilbourne AM, Goodrich DE, Nord KM, VanPoppelen C, Clogston J, Bauer MS, Waxmonsky JA, Lai Z, Kim HM, Eisenberg D, Thomas MR: Long-term clinical outcomes from a randomized controlled trial of two implementation strategies to promote collaborative care attendance in community practices.<italic>Adm Policy in Mental Health</italic>, in press.,</mixed-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Post</surname><given-names>EP</given-names></name><name><surname>Nossek</surname><given-names>A</given-names></name><name><surname>Drill</surname><given-names>L</given-names></name><name><surname>Cooley</surname><given-names>S</given-names></name><name><surname>Bauer</surname><given-names>MS</given-names></name></person-group><article-title>Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial</article-title><source>Psychiatr Serv</source><year>2008</year><volume>59</volume><fpage>760</fpage><lpage>768</lpage><pub-id pub-id-type="doi">10.1176/ps.2008.59.7.760</pub-id><pub-id pub-id-type="pmid">18586993</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>GE</given-names></name><name><surname>Ludman</surname><given-names>EJ</given-names></name><name><surname>Bauer</surname><given-names>MS</given-names></name><name><surname>Unutzer</surname><given-names>J</given-names></name><name><surname>Operskalski</surname><given-names>B</given-names></name></person-group><article-title>Long-term effectiveness and cost of a systematic care program for bipolar disorder</article-title><source>Arch Gen Psychiatry</source><year>2006</year><volume>63</volume><fpage>500</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.63.5.500</pub-id><pub-id pub-id-type="pmid">16651507</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Goodrich</surname><given-names>DE</given-names></name><name><surname>Lai</surname><given-names>Z</given-names></name><name><surname>Clogston</surname><given-names>J</given-names></name><name><surname>Waxmonsky</surname><given-names>J</given-names></name><name><surname>Bauer</surname><given-names>MS</given-names></name></person-group><article-title>Life Goals Collaborative Care for patients with bipolar disorder and cardiovascular disease risk</article-title><source>Psychiatr Serv</source><year>2012</year><volume>63</volume><fpage>1234</fpage><lpage>1238</lpage><pub-id pub-id-type="doi">10.1176/appi.ps.201100528</pub-id><pub-id pub-id-type="pmid">23203358</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Lai</surname><given-names>Z</given-names></name><name><surname>Waxmonsky</surname><given-names>J</given-names></name><name><surname>Ketter</surname><given-names>T</given-names></name></person-group><article-title>Pilot randomized trial of a cross-diagnosis collaborative care program for patients with mood disorders</article-title><source>Depress Anxiety</source><year>2013</year><volume>30</volume><fpage>116</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1002/da.22003</pub-id><pub-id pub-id-type="pmid">23077119</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>MS</given-names></name><name><surname>McBride</surname><given-names>L</given-names></name><name><surname>Williford</surname><given-names>WO</given-names></name><name><surname>Glick</surname><given-names>H</given-names></name><name><surname>Kinosian</surname><given-names>B</given-names></name><name><surname>Altshuler</surname><given-names>L</given-names></name><name><surname>Beresford</surname><given-names>T</given-names></name><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Sajatovic</surname><given-names>M</given-names></name></person-group><article-title>Collaborative care for bipolar disorder: part II. Impact on clinical outcome, function, and costs</article-title><source>Psychiatr Serv</source><year>2006</year><volume>57</volume><fpage>937</fpage><lpage>945</lpage><pub-id pub-id-type="doi">10.1176/ps.2006.57.7.937</pub-id><pub-id pub-id-type="pmid">16816277</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>H</given-names></name><name><surname>Nahum-Shani</surname><given-names>I</given-names></name><name><surname>Lynch</surname><given-names>K</given-names></name><name><surname>Oslin</surname><given-names>D</given-names></name><name><surname>Murphy</surname><given-names>SA</given-names></name></person-group><article-title>A “SMART” design for building individualized treatment sequences</article-title><source>Annu Rev Clin Psychol</source><year>2012</year><volume>8</volume><fpage>21</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1146/annurev-clinpsy-032511-143152</pub-id><pub-id pub-id-type="pmid">22224838</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almirall</surname><given-names>D</given-names></name><name><surname>Compton</surname><given-names>SN</given-names></name><name><surname>Gunlicks-Stoessel</surname><given-names>M</given-names></name><name><surname>Duan</surname><given-names>N</given-names></name><name><surname>Murphy</surname><given-names>SA</given-names></name></person-group><article-title>Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy</article-title><source>Stat Med</source><year>2012</year><volume>31</volume><fpage>1887</fpage><lpage>1902</lpage><pub-id pub-id-type="doi">10.1002/sim.4512</pub-id><pub-id pub-id-type="pmid">22438190</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Goodrich</surname><given-names>DE</given-names></name><name><surname>Lai</surname><given-names>Z</given-names></name><name><surname>Post</surname><given-names>EP</given-names></name><name><surname>Schumacher</surname><given-names>K</given-names></name><name><surname>Nord</surname><given-names>KM</given-names></name><name><surname>Bramlet</surname><given-names>M</given-names></name><name><surname>Chermack</surname><given-names>S</given-names></name><name><surname>Bialy</surname><given-names>D</given-names></name><name><surname>Bauer</surname><given-names>MS</given-names></name></person-group><article-title>Randomized controlled trial to assess reduction of cardiovascular disease risk in patients with bipolar disorder: the Self-Management Addressing Heart Risk Trial (SMAHRT)</article-title><source>J Clin Psychiatry</source><year>2013</year><volume>74</volume><fpage>e655</fpage><lpage>e662</lpage><pub-id pub-id-type="doi">10.4088/JCP.12m08082</pub-id><pub-id pub-id-type="pmid">23945460</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>AM</given-names></name><name><surname>Azzone</surname><given-names>V</given-names></name><name><surname>Goldman</surname><given-names>HH</given-names></name><name><surname>Alexander</surname><given-names>L</given-names></name><name><surname>Unutzer</surname><given-names>J</given-names></name><name><surname>Coleman-Beattie</surname><given-names>B</given-names></name><name><surname>Frank</surname><given-names>RG</given-names></name></person-group><article-title>Implementation of collaborative depression management at community-based primary care clinics: an evaluation</article-title><source>Psychiatr Serv</source><year>2011</year><volume>62</volume><fpage>1047</fpage><lpage>1053</lpage><pub-id pub-id-type="doi">10.1176/ps.62.9.pss6209_1047</pub-id><pub-id pub-id-type="pmid">21885583</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>NW</given-names></name><name><surname>McPherson</surname><given-names>GC</given-names></name><name><surname>Ramsay</surname><given-names>CR</given-names></name><name><surname>Campbell</surname><given-names>MK</given-names></name></person-group><article-title>The method of minimization for allocation to clinical trials. A review</article-title><source>Control Clin Trials</source><year>2002</year><volume>23</volume><fpage>662</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1016/S0197-2456(02)00242-8</pub-id><pub-id pub-id-type="pmid">12505244</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taves</surname><given-names>DR</given-names></name></person-group><article-title>Minimization: a new method of assigning patients to treatment and control groups</article-title><source>Clin Pharmacol Ther</source><year>1974</year><volume>15</volume><fpage>443</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1002/cpt1974155443</pub-id><pub-id pub-id-type="pmid">4597226</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Post</surname><given-names>EP</given-names></name><name><surname>Nossek</surname><given-names>A</given-names></name><name><surname>Sonel</surname><given-names>E</given-names></name><name><surname>Drill</surname><given-names>LJ</given-names></name><name><surname>Cooley</surname><given-names>S</given-names></name><name><surname>Bauer</surname><given-names>MS</given-names></name></person-group><article-title>Service delivery in older patients with bipolar disorder: a review and development of a medical care model</article-title><source>Bipolar Disord</source><year>2008</year><volume>10</volume><fpage>672</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1111/j.1399-5618.2008.00602.x</pub-id><pub-id pub-id-type="pmid">18837861</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bandura</surname><given-names>A</given-names></name></person-group><source>Social Foundations of Thought and Action: A Social Cognitive Theory</source><year>1996</year><publisher-loc>Prentice Hall</publisher-loc><publisher-name>Englewood Cliffs</publisher-name></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandura</surname><given-names>A</given-names></name></person-group><article-title>The primacy of self-regulation in health promotion</article-title><source>Appl Psychol Int Rev</source><year>2005</year><volume>54</volume><issue>2</issue><fpage>245</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1111/j.1464-0597.2005.00208.x</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>RC</given-names></name><name><surname>Wang</surname><given-names>PS</given-names></name></person-group><article-title>The descriptive epidemiology of commonly occurring mental disorders in the United States</article-title><source>Annu Rev Public Health</source><year>2008</year><volume>29</volume><fpage>115</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1146/annurev.publhealth.29.020907.090847</pub-id><pub-id pub-id-type="pmid">18348707</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Judd</surname><given-names>LL</given-names></name><name><surname>Akiskal</surname><given-names>HS</given-names></name></person-group><article-title>The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases</article-title><source>J Affect Disord</source><year>2003</year><volume>73</volume><fpage>123</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1016/S0165-0327(02)00332-4</pub-id><pub-id pub-id-type="pmid">12507745</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Biswas</surname><given-names>K</given-names></name><name><surname>Pirraglia</surname><given-names>PA</given-names></name><name><surname>Sajatovic</surname><given-names>M</given-names></name><name><surname>Williford</surname><given-names>WO</given-names></name><name><surname>Bauer</surname><given-names>MS</given-names></name></person-group><article-title>Is the collaborative chronic care model effective for patients with bipolar disorder and co-occurring conditions?</article-title><source>J Affect Disord</source><year>2009</year><volume>112</volume><fpage>256</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2008.04.010</pub-id><pub-id pub-id-type="pmid">18504059</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Neumann</surname><given-names>MS</given-names></name><name><surname>Waxmonsky</surname><given-names>J</given-names></name><name><surname>Bauer</surname><given-names>MS</given-names></name><name><surname>Kim</surname><given-names>HM</given-names></name><name><surname>Pincus</surname><given-names>HA</given-names></name><name><surname>Thomas</surname><given-names>M</given-names></name></person-group><article-title>Public-academic partnerships: evidence-based implementation: the role of sustained community-based practice and research partnerships</article-title><source>Psychiatr Serv</source><year>2012</year><volume>63</volume><fpage>205</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1176/appi.ps.201200032</pub-id><pub-id pub-id-type="pmid">22388527</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>MS</given-names></name><name><surname>Sogolow</surname><given-names>ED</given-names></name></person-group><article-title>Replicating effective programs: HIV/AIDS prevention technology transfer</article-title><source>AIDS Educ Prev</source><year>2000</year><volume>12</volume><fpage>35</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">11063068</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>J</given-names></name><name><surname>Terry</surname><given-names>MA</given-names></name><name><surname>Rebchook</surname><given-names>GM</given-names></name><name><surname>O'Donnell</surname><given-names>L</given-names></name><name><surname>Kelly</surname><given-names>JA</given-names></name><name><surname>Leonard</surname><given-names>NR</given-names></name><name><surname>Neumann</surname><given-names>MS</given-names></name></person-group><article-title>Orientation and training: preparing agency administrators and staff to replicate an HIV prevention intervention</article-title><source>AIDS Educ Prev</source><year>2000</year><volume>12</volume><fpage>75</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">11063071</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Donnell</surname><given-names>L</given-names></name><name><surname>Scattergood</surname><given-names>P</given-names></name><name><surname>Adler</surname><given-names>M</given-names></name><name><surname>Doval</surname><given-names>AS</given-names></name><name><surname>Barker</surname><given-names>M</given-names></name><name><surname>Kelly</surname><given-names>JA</given-names></name><name><surname>Kegeles</surname><given-names>SM</given-names></name><name><surname>Rebchook</surname><given-names>GM</given-names></name><name><surname>Adams</surname><given-names>J</given-names></name><name><surname>Terry</surname><given-names>MA</given-names></name><name><surname>Neumann</surname><given-names>MS</given-names></name></person-group><article-title>The role of technical assistance in the replication of effective HIV interventions</article-title><source>AIDS Educ Prev</source><year>2000</year><volume>12</volume><fpage>99</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">11063073</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bandura</surname><given-names>A</given-names></name></person-group><source>Social Learning Theory</source><year>1977</year><publisher-loc>Prentice Hall</publisher-loc><publisher-name>Englewood Cliffs</publisher-name></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>MS</given-names></name><name><surname>McBride</surname><given-names>L</given-names></name></person-group><source>Structured Group Psychotherapy for Bipolar Disorder: The Life Goals Program</source><year>2003</year><publisher-loc>New York</publisher-loc><publisher-name>Springer</publisher-name></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>MS</given-names></name><name><surname>McBride</surname><given-names>L</given-names></name><name><surname>Williford</surname><given-names>WO</given-names></name><name><surname>Glick</surname><given-names>H</given-names></name><name><surname>Kinosian</surname><given-names>B</given-names></name><name><surname>Altshuler</surname><given-names>L</given-names></name><name><surname>Beresford</surname><given-names>T</given-names></name><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Sajatovic</surname><given-names>M</given-names></name></person-group><article-title>Collaborative care for bipolar disorder: part I. Intervention and implementation in a randomized effectiveness trial</article-title><source>Psychiatr Serv</source><year>2006</year><volume>57</volume><fpage>927</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.1176/ps.2006.57.7.927</pub-id><pub-id pub-id-type="pmid">16816276</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>GE</given-names></name><name><surname>Ludman</surname><given-names>E</given-names></name><name><surname>Unutzer</surname><given-names>J</given-names></name><name><surname>Bauer</surname><given-names>MS</given-names></name></person-group><article-title>Design and implementation of a randomized trial evaluating systematic care for bipolar disorder</article-title><source>Bipolar Disord</source><year>2002</year><volume>4</volume><fpage>226</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1034/j.1399-5618.2002.01190.x</pub-id><pub-id pub-id-type="pmid">12190711</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stetler</surname><given-names>CB</given-names></name><name><surname>Damschroder</surname><given-names>LJ</given-names></name><name><surname>Helfrich</surname><given-names>CD</given-names></name><name><surname>Hagedorn</surname><given-names>HJ</given-names></name></person-group><article-title>A guide for applying a revised version of the PARIHS framework for implementation</article-title><source>Implement Sci</source><year>2011</year><volume>6</volume><fpage>99</fpage><pub-id pub-id-type="doi">10.1186/1748-5908-6-99</pub-id><pub-id pub-id-type="pmid">21878092</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitson</surname><given-names>AL</given-names></name><name><surname>Rycroft-Malone</surname><given-names>J</given-names></name><name><surname>Harvey</surname><given-names>G</given-names></name><name><surname>McCormack</surname><given-names>B</given-names></name><name><surname>Seers</surname><given-names>K</given-names></name><name><surname>Titchen</surname><given-names>A</given-names></name></person-group><article-title>Evaluating the successful implementation of evidence into practice using the PARiHS framework: theoretical and practical challenges</article-title><source>Implement Sci</source><year>2008</year><volume>3</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.1186/1748-5908-3-1</pub-id><pub-id pub-id-type="pmid">18179688</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitson</surname><given-names>A</given-names></name><name><surname>Harvey</surname><given-names>G</given-names></name><name><surname>McCormack</surname><given-names>B</given-names></name></person-group><article-title>Enabling the implementation of evidence based practice: a conceptual framework</article-title><source>Qual Health Care</source><year>1998</year><volume>7</volume><fpage>149</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1136/qshc.7.3.149</pub-id><pub-id pub-id-type="pmid">10185141</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>G</given-names></name><name><surname>Loftus-Hills</surname><given-names>A</given-names></name><name><surname>Rycroft-Malone</surname><given-names>J</given-names></name><name><surname>Titchen</surname><given-names>A</given-names></name><name><surname>Kitson</surname><given-names>A</given-names></name><name><surname>McCormack</surname><given-names>B</given-names></name><name><surname>Seers</surname><given-names>K</given-names></name></person-group><article-title>Getting evidence into practice: the role and function of facilitation</article-title><source>J Adv Nurs</source><year>2002</year><volume>37</volume><fpage>577</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2648.2002.02126.x</pub-id><pub-id pub-id-type="pmid">11879422</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stetler</surname><given-names>CB</given-names></name><name><surname>Legro</surname><given-names>MW</given-names></name><name><surname>Rycroft-Malone</surname><given-names>J</given-names></name><name><surname>Bowman</surname><given-names>C</given-names></name><name><surname>Curran</surname><given-names>G</given-names></name><name><surname>Guihan</surname><given-names>M</given-names></name><name><surname>Hagedorn</surname><given-names>H</given-names></name><name><surname>Pineros</surname><given-names>S</given-names></name><name><surname>Wallace</surname><given-names>CM</given-names></name></person-group><article-title>Role of “external facilitation” in implementation of research findings: a qualitative evaluation of facilitation experiences in the Veterans Health Administration</article-title><source>Implement Sci</source><year>2006</year><volume>1</volume><fpage>23</fpage><pub-id pub-id-type="doi">10.1186/1748-5908-1-23</pub-id><pub-id pub-id-type="pmid">17049080</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glasgow</surname><given-names>RE</given-names></name><name><surname>Vogt</surname><given-names>TM</given-names></name><name><surname>Boles</surname><given-names>SM</given-names></name></person-group><article-title>Evaluating the public health impact of health promotion interventions: the RE-AIM framework</article-title><source>Am J Public Health</source><year>1999</year><volume>89</volume><fpage>1322</fpage><lpage>1327</lpage><pub-id pub-id-type="doi">10.2105/AJPH.89.9.1322</pub-id><pub-id pub-id-type="pmid">10474547</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fortney</surname><given-names>J</given-names></name><name><surname>Enderle</surname><given-names>M</given-names></name><name><surname>McDougall</surname><given-names>S</given-names></name><name><surname>Clothier</surname><given-names>J</given-names></name><name><surname>Otero</surname><given-names>J</given-names></name><name><surname>Altman</surname><given-names>L</given-names></name><name><surname>Curran</surname><given-names>G</given-names></name></person-group><article-title>Implementation outcomes of evidence-based quality improvement for depression in VA community based outpatient clinics</article-title><source>Implement Sci</source><year>2012</year><volume>7</volume><fpage>30</fpage><pub-id pub-id-type="doi">10.1186/1748-5908-7-30</pub-id><pub-id pub-id-type="pmid">22494428</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenn</surname><given-names>HH</given-names></name><name><surname>Bauer</surname><given-names>MS</given-names></name><name><surname>Altshuler</surname><given-names>L</given-names></name><name><surname>Evans</surname><given-names>DR</given-names></name><name><surname>Williford</surname><given-names>WO</given-names></name><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Beresford</surname><given-names>TP</given-names></name><name><surname>Kirk</surname><given-names>G</given-names></name><name><surname>Stedman</surname><given-names>M</given-names></name><name><surname>Fiore</surname><given-names>L</given-names></name></person-group><article-title>Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span</article-title><source>J Affect Disord</source><year>2005</year><volume>86</volume><fpage>47</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2004.12.006</pub-id><pub-id pub-id-type="pmid">15820270</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Post</surname><given-names>EP</given-names></name><name><surname>Bauer</surname><given-names>MS</given-names></name><name><surname>Zeber</surname><given-names>JE</given-names></name><name><surname>Copeland</surname><given-names>LA</given-names></name><name><surname>Good</surname><given-names>CB</given-names></name><name><surname>Pincus</surname><given-names>HA</given-names></name></person-group><article-title>Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder</article-title><source>J Affect Disord</source><year>2007</year><volume>102</volume><fpage>145</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2007.01.006</pub-id><pub-id pub-id-type="pmid">17276514</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Farmer Teh</surname><given-names>C</given-names></name><name><surname>Welsh</surname><given-names>D</given-names></name><name><surname>Pincus</surname><given-names>HA</given-names></name><name><surname>Lasky</surname><given-names>E</given-names></name><name><surname>Perron</surname><given-names>B</given-names></name><name><surname>Bauer</surname><given-names>MS</given-names></name></person-group><article-title>Implementing composite quality metrics for bipolar disorder: towards a more comprehensive approach to quality measurement</article-title><source>Gen Hosp Psychiatr</source><year>2010</year><volume>32</volume><fpage>636</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1016/j.genhosppsych.2010.09.011</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ware</surname><given-names>J</given-names><suffix>Jr</suffix></name><name><surname>Kosinski</surname><given-names>M</given-names></name><name><surname>Keller</surname><given-names>SD</given-names></name></person-group><article-title>A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity</article-title><source>Med Care</source><year>1996</year><volume>34</volume><fpage>220</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1097/00005650-199603000-00003</pub-id><pub-id pub-id-type="pmid">8628042</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroenke</surname><given-names>K</given-names></name><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Williams</surname><given-names>JB</given-names></name></person-group><article-title>The PHQ-9: validity of a brief depression severity measure</article-title><source>J Gen Intern Med</source><year>2001</year><volume>16</volume><fpage>606</fpage><lpage>613</lpage><pub-id pub-id-type="doi">10.1046/j.1525-1497.2001.016009606.x</pub-id><pub-id pub-id-type="pmid">11556941</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Kroenke</surname><given-names>K</given-names></name><name><surname>Williams</surname><given-names>JB</given-names></name></person-group><article-title>Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study</article-title><source>Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA</source><year>1999</year><volume>282</volume><fpage>1737</fpage><lpage>1744</lpage><pub-id pub-id-type="pmid">10568646</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ustun</surname><given-names>TB</given-names></name><name><surname>Chisholm</surname><given-names>D</given-names></name></person-group><article-title>Global “burden of disease”-study for psychiatric disorders</article-title><source>Psychiatr Prax</source><year>2001</year><volume>28</volume><issue>Suppl 1</issue><fpage>S7</fpage><lpage>S11</lpage><pub-id pub-id-type="doi">10.1055/s-2001-15381</pub-id><pub-id pub-id-type="pmid">11533901</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehm</surname><given-names>J</given-names></name><name><surname>Ustun</surname><given-names>TB</given-names></name><name><surname>Saxena</surname><given-names>S</given-names></name><name><surname>Nelson</surname><given-names>CB</given-names></name><name><surname>Chatterji</surname><given-names>S</given-names></name><name><surname>Ivis</surname><given-names>F</given-names></name><name><surname>Adlaf</surname><given-names>E</given-names></name></person-group><article-title>On the development and psychometric testing of the WHO screening instrument to assess disablement in the general population</article-title><source>Int J Methods Psychiatr Res</source><year>1999</year><volume>8</volume><fpage>110</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1002/mpr.61</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Kroenke</surname><given-names>K</given-names></name><name><surname>Williams</surname><given-names>JB</given-names></name><name><surname>Lowe</surname><given-names>B</given-names></name></person-group><article-title>A brief measure for assessing generalized anxiety disorder: the GAD-7</article-title><source>Arch Intern Med</source><year>2006</year><volume>166</volume><fpage>1092</fpage><lpage>1097</lpage><pub-id pub-id-type="doi">10.1001/archinte.166.10.1092</pub-id><pub-id pub-id-type="pmid">16717171</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>MS</given-names></name><name><surname>Vojta</surname><given-names>C</given-names></name><name><surname>Kinosian</surname><given-names>B</given-names></name><name><surname>Altshuler</surname><given-names>L</given-names></name><name><surname>Glick</surname><given-names>H</given-names></name></person-group><article-title>The Internal State Scale: replication of its discriminating abilities in a multisite, public sector sample</article-title><source>Bipolar Disord</source><year>2000</year><volume>2</volume><fpage>340</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1034/j.1399-5618.2000.020409.x</pub-id><pub-id pub-id-type="pmid">11252648</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glick</surname><given-names>HA</given-names></name><name><surname>McBride</surname><given-names>L</given-names></name><name><surname>Bauer</surname><given-names>MS</given-names></name></person-group><article-title>A manic-depressive symptom self-report in optical scanable format</article-title><source>Bipolar Disord</source><year>2003</year><volume>5</volume><fpage>366</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1034/j.1399-5618.2003.00043.x</pub-id><pub-id pub-id-type="pmid">14525558</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>AJ</given-names></name><name><surname>Maisto</surname><given-names>SA</given-names></name><name><surname>McNeil</surname><given-names>M</given-names></name><name><surname>Kraemer</surname><given-names>KL</given-names></name><name><surname>Conigliaro</surname><given-names>RL</given-names></name><name><surname>Kelley</surname><given-names>ME</given-names></name><name><surname>Conigliaro</surname><given-names>J</given-names></name></person-group><article-title>Three questions can detect hazardous drinkers</article-title><source>J Fam Pract</source><year>2001</year><volume>50</volume><fpage>313</fpage><lpage>320</lpage><pub-id pub-id-type="pmid">11300982</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>RC</given-names></name><name><surname>Andrews</surname><given-names>G</given-names></name><name><surname>Mroczek</surname><given-names>D</given-names></name><name><surname>Ustun</surname><given-names>TB</given-names></name><name><surname>Wittchen</surname><given-names>HU</given-names></name></person-group><article-title>The World Health Organization Composite International Diagnostic Interview short-form (CIDI-SF)</article-title><source>Int J Methods Psychiatr Res</source><year>1998</year><volume>7</volume><fpage>171</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1002/mpr.47</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chyba</surname><given-names>MM</given-names></name><name><surname>Washington</surname><given-names>LR</given-names></name></person-group><article-title>Questionnaires from the National Health Interview Survey, 1985-89</article-title><source>Vital Health Stat Ser</source><year>1993</year><volume>1</volume><fpage>1</fpage><lpage>412</lpage></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Good</surname><given-names>CB</given-names></name><name><surname>Sereika</surname><given-names>SM</given-names></name><name><surname>Justice</surname><given-names>AC</given-names></name><name><surname>Fine</surname><given-names>MJ</given-names></name></person-group><article-title>Algorithm for assessing patients' adherence to oral hypoglycemic medication</article-title><source>Am J Health Syst Pharm</source><year>2005</year><volume>62</volume><fpage>198</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">15700895</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Post</surname><given-names>EP</given-names></name><name><surname>Kilbourne</surname><given-names>AM</given-names></name><name><surname>Bremer</surname><given-names>RW</given-names></name><name><surname>Solano</surname><given-names>FX</given-names><suffix>Jr</suffix></name><name><surname>Pincus</surname><given-names>HA</given-names></name><name><surname>Reynolds</surname><given-names>CF</given-names><suffix>3rd</suffix></name></person-group><article-title>Organizational factors and depression management in community-based primary care settings</article-title><source>Implement Sci</source><year>2009</year><volume>4</volume><fpage>84</fpage><pub-id pub-id-type="doi">10.1186/1748-5908-4-84</pub-id><pub-id pub-id-type="pmid">20043838</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aarons</surname><given-names>GA</given-names></name><name><surname>Ehrhart</surname><given-names>MG</given-names></name><name><surname>Farahnak</surname><given-names>LR</given-names></name></person-group><article-title>The Implementation Leadership Scale (ILS): development of a brief measure of unit level implementation leadership</article-title><source>Implement Sci</source><year>2014</year><volume>9</volume><fpage>45</fpage><pub-id pub-id-type="doi">10.1186/1748-5908-9-45</pub-id><pub-id pub-id-type="pmid">24731295</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodrich</surname><given-names>DE</given-names></name><name><surname>Bowersox</surname><given-names>NW</given-names></name><name><surname>Abraham</surname><given-names>KM</given-names></name><name><surname>Burk</surname><given-names>JP</given-names></name><name><surname>Visnic</surname><given-names>S</given-names></name><name><surname>Lai</surname><given-names>Z</given-names></name><name><surname>Kilbourne</surname><given-names>AM</given-names></name></person-group><article-title>Leading from the middle: replication of a re-engagement program for veterans with mental disorders lost to follow-up care</article-title><source>Depress Res Treat</source><year>2012</year><volume>2012</volume><fpage>325249</fpage><pub-id pub-id-type="pmid">23050134</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Verbeke</surname><given-names>G</given-names></name><name><surname>Molenberghs</surname><given-names>G</given-names></name></person-group><source>Linear Mixed Models for Longitudinal Data</source><year>2009</year><publisher-loc>New York</publisher-loc><publisher-name>Springer</publisher-name></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackinnon</surname><given-names>DP</given-names></name><name><surname>Fairchild</surname><given-names>AJ</given-names></name></person-group><article-title>Current directions in mediation analysis</article-title><source>Curr Dir Psychol Sci</source><year>2009</year><volume>18</volume><fpage>16</fpage><pub-id pub-id-type="doi">10.1111/j.1467-8721.2009.01598.x</pub-id><pub-id pub-id-type="pmid">20157637</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orellana</surname><given-names>L</given-names></name><name><surname>Rotnitzky</surname><given-names>A</given-names></name><name><surname>Robins</surname><given-names>JM</given-names></name></person-group><article-title>Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part II: proofs of results</article-title><source>Int J Biostat</source><year>2010</year><volume>6</volume><fpage>Article 9</fpage><pub-id pub-id-type="pmid">20405047</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robins</surname><given-names>JM</given-names></name></person-group><article-title>Causal models for estimating the effects of weight gain on mortality</article-title><source>Int J Obes (Lond)</source><year>2008</year><volume>32</volume><issue>Suppl 3</issue><fpage>S15</fpage><lpage>S41</lpage><pub-id pub-id-type="doi">10.1038/ijo.2008.83</pub-id><pub-id pub-id-type="pmid">18695650</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Schafer</surname><given-names>JL</given-names></name></person-group><source>Analysis of Incomplete Multivariate Data</source><year>1997</year><publisher-loc>London</publisher-loc><publisher-name>Chapman and Hall</publisher-name></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damschroder</surname><given-names>LJ</given-names></name><name><surname>Aron</surname><given-names>DC</given-names></name><name><surname>Keith</surname><given-names>RE</given-names></name><name><surname>Kirsh</surname><given-names>SR</given-names></name><name><surname>Alexander</surname><given-names>JA</given-names></name><name><surname>Lowery</surname><given-names>JC</given-names></name></person-group><article-title>Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science</article-title><source>Implement Sci</source><year>2009</year><volume>4</volume><fpage>50</fpage><pub-id pub-id-type="doi">10.1186/1748-5908-4-50</pub-id><pub-id pub-id-type="pmid">19664226</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>SS</given-names></name><name><surname>van Ryn</surname><given-names>M</given-names></name><name><surname>Sherman</surname><given-names>SE</given-names></name><name><surname>Burgess</surname><given-names>DJ</given-names></name><name><surname>Noorbaloochi</surname><given-names>S</given-names></name><name><surname>Clothier</surname><given-names>B</given-names></name><name><surname>Taylor</surname><given-names>BC</given-names></name><name><surname>Schlede</surname><given-names>CM</given-names></name><name><surname>Burke</surname><given-names>RS</given-names></name><name><surname>Joseph</surname><given-names>AM</given-names></name></person-group><article-title>Proactive tobacco treatment and population-level cessation: a pragmatic randomized clinical trial</article-title><source>JAMA Inter Med</source><year>2014</year><volume>174</volume><fpage>671</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1001/jamainternmed.2014.177</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pletcher</surname><given-names>MJ</given-names></name><name><surname>Lo</surname><given-names>B</given-names></name><name><surname>Grady</surname><given-names>D</given-names></name></person-group><article-title>Informed consent in randomized quality improvement trials: a critical barrier for learning health systems</article-title><source>JAMA Intern Med</source><year>2014</year><volume>174</volume><fpage>668</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1001/jamainternmed.2013.13297</pub-id><pub-id pub-id-type="pmid">24615554</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendel</surname><given-names>P</given-names></name><name><surname>Meredith</surname><given-names>LS</given-names></name><name><surname>Schoenbaum</surname><given-names>M</given-names></name><name><surname>Sherbourne</surname><given-names>CD</given-names></name><name><surname>Wells</surname><given-names>KB</given-names></name></person-group><article-title>Interventions in organizational and community context: a framework for building evidence on dissemination and implementation in health services research</article-title><source>Adm Policy Ment Health</source><year>2008</year><volume>35</volume><fpage>21</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1007/s10488-007-0144-9</pub-id><pub-id pub-id-type="pmid">17990095</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pincus</surname><given-names>HA</given-names></name><name><surname>Hough</surname><given-names>L</given-names></name><name><surname>Houtsinger</surname><given-names>JK</given-names></name><name><surname>Rollman</surname><given-names>BL</given-names></name><name><surname>Frank</surname><given-names>RG</given-names></name></person-group><article-title>Emerging models of depression care: multi-level ('6 P') strategies</article-title><source>Int J Methods Psychiatr Res</source><year>2003</year><volume>12</volume><fpage>54</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1002/mpr.142</pub-id><pub-id pub-id-type="pmid">12830310</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>RG</given-names></name><name><surname>Huskamp</surname><given-names>HA</given-names></name><name><surname>Pincus</surname><given-names>HA</given-names></name></person-group><article-title>Aligning incentives in the treatment of depression in primary care with evidence-based practice</article-title><source>Psychiatr Serv</source><year>2003</year><volume>54</volume><fpage>682</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1176/appi.ps.54.5.682</pub-id><pub-id pub-id-type="pmid">12719498</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>AM</given-names></name><name><surname>Blustein</surname><given-names>J</given-names></name><name><surname>Casalino</surname><given-names>LP</given-names></name></person-group><article-title>Medicare's flagship test of pay-for-performance did not spur more rapid quality improvement among low-performing hospitals</article-title><source>Health Aff (Millwood)</source><year>2012</year><volume>31</volume><fpage>797</fpage><lpage>805</lpage><pub-id pub-id-type="doi">10.1377/hlthaff.2011.0626</pub-id><pub-id pub-id-type="pmid">22492897</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname><given-names>RM</given-names></name><name><surname>Kolstad</surname><given-names>JT</given-names></name><name><surname>Stuart</surname><given-names>EA</given-names></name><name><surname>Polsky</surname><given-names>D</given-names></name></person-group><article-title>The effect of pay-for-performance in hospitals: lessons for quality improvement</article-title><source>Health Aff (Millwood)</source><year>2011</year><volume>30</volume><fpage>690</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1377/hlthaff.2010.1277</pub-id><pub-id pub-id-type="pmid">21471490</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillman</surname><given-names>AL</given-names></name><name><surname>Ripley</surname><given-names>K</given-names></name><name><surname>Goldfarb</surname><given-names>N</given-names></name><name><surname>Weiner</surname><given-names>J</given-names></name><name><surname>Nuamah</surname><given-names>I</given-names></name><name><surname>Lusk</surname><given-names>E</given-names></name></person-group><article-title>The use of physician financial incentives and feedback to improve pediatric preventive care in Medicaid managed care</article-title><source>Pediatrics</source><year>1999</year><volume>104</volume><fpage>931</fpage><lpage>935</lpage><pub-id pub-id-type="doi">10.1542/peds.104.4.931</pub-id><pub-id pub-id-type="pmid">10506237</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>LE</given-names></name><name><surname>Kirchner</surname><given-names>JE</given-names></name><name><surname>Bonner</surname><given-names>LM</given-names></name><name><surname>Fickel</surname><given-names>JJ</given-names></name><name><surname>Ritchie</surname><given-names>MJ</given-names></name><name><surname>Simons</surname><given-names>CE</given-names></name><name><surname>Yano</surname><given-names>EM</given-names></name></person-group><article-title>Creating a quality-improvement dialogue: utilizing knowledge from frontline staff, managers, and experts to foster health care quality improvement</article-title><source>Qual Health Res</source><year>2009</year><volume>19</volume><fpage>229</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1177/1049732308329481</pub-id><pub-id pub-id-type="pmid">19092141</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubenstein</surname><given-names>LV</given-names></name><name><surname>Parker</surname><given-names>LE</given-names></name><name><surname>Meredith</surname><given-names>LS</given-names></name><name><surname>Altschuler</surname><given-names>A</given-names></name><name><surname>DePillis</surname><given-names>E</given-names></name><name><surname>Hernandez</surname><given-names>J</given-names></name><name><surname>Gordon</surname><given-names>NP</given-names></name></person-group><article-title>Understanding team-based quality improvement for depression in primary care</article-title><source>Health Serv Res</source><year>2002</year><volume>37</volume><fpage>1009</fpage><lpage>1029</lpage><pub-id pub-id-type="doi">10.1034/j.1600-0560.2002.63.x</pub-id><pub-id pub-id-type="pmid">12236381</pub-id></element-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glasgow</surname><given-names>RE</given-names></name><name><surname>Emmons</surname><given-names>KM</given-names></name></person-group><article-title>How can we increase translation of research into practice? Types of evidence needed</article-title><source>Annu Rev Public Health</source><year>2007</year><volume>28</volume><fpage>413</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1146/annurev.publhealth.28.021406.144145</pub-id><pub-id pub-id-type="pmid">17150029</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birken</surname><given-names>SA</given-names></name><name><surname>Lee</surname><given-names>SY</given-names></name><name><surname>Weiner</surname><given-names>BJ</given-names></name></person-group><article-title>Uncovering middle managers' role in healthcare innovation implementation</article-title><source>Implement Sci</source><year>2012</year><volume>7</volume><fpage>28</fpage><pub-id pub-id-type="doi">10.1186/1748-5908-7-28</pub-id><pub-id pub-id-type="pmid">22472001</pub-id></element-citation></ref><ref id="CR113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>LE</given-names></name><name><surname>de Pillis</surname><given-names>E</given-names></name><name><surname>Altschuler</surname><given-names>A</given-names></name><name><surname>Rubenstein</surname><given-names>LV</given-names></name><name><surname>Meredith</surname><given-names>LS</given-names></name></person-group><article-title>Balancing participation and expertise: a comparison of locally and centrally managed health care quality improvement within primary care practices</article-title><source>Qual Health Res</source><year>2007</year><volume>17</volume><fpage>1268</fpage><lpage>1279</lpage><pub-id pub-id-type="doi">10.1177/1049732307307447</pub-id><pub-id pub-id-type="pmid">17968043</pub-id></element-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenhalgh</surname><given-names>T</given-names></name><name><surname>Robert</surname><given-names>G</given-names></name><name><surname>Macfarlane</surname><given-names>F</given-names></name><name><surname>Bate</surname><given-names>P</given-names></name><name><surname>Kyriakidou</surname><given-names>O</given-names></name></person-group><article-title>Diffusion of innovations in service organizations: systematic review and recommendations</article-title><source>Milbank Q</source><year>2004</year><volume>82</volume><fpage>581</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1111/j.0887-378X.2004.00325.x</pub-id><pub-id pub-id-type="pmid">15595944</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginsburg</surname><given-names>LR</given-names></name><name><surname>Lewis</surname><given-names>S</given-names></name><name><surname>Zackheim</surname><given-names>L</given-names></name><name><surname>Casebeer</surname><given-names>A</given-names></name></person-group><article-title>Revisiting interaction in knowledge translation</article-title><source>Implement Sci</source><year>2007</year><volume>2</volume><fpage>34</fpage><pub-id pub-id-type="doi">10.1186/1748-5908-2-34</pub-id><pub-id pub-id-type="pmid">17971208</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stange</surname><given-names>KC</given-names></name><name><surname>Goodwin</surname><given-names>MA</given-names></name><name><surname>Zyzanski</surname><given-names>SJ</given-names></name><name><surname>Dietrich</surname><given-names>AJ</given-names></name></person-group><article-title>Sustainability of a practice-individualized preventive service delivery intervention</article-title><source>Am J Prev Med</source><year>2003</year><volume>25</volume><fpage>296</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1016/S0749-3797(03)00219-8</pub-id><pub-id pub-id-type="pmid">14580630</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubenstein</surname><given-names>LV</given-names></name><name><surname>Mittman</surname><given-names>BS</given-names></name><name><surname>Yano</surname><given-names>EM</given-names></name><name><surname>Mulrow</surname><given-names>CD</given-names></name></person-group><article-title>From understanding health care provider behavior to improving health care: the QUERI framework for quality improvement. Quality Enhancement Research Initiative</article-title><source>Med Care</source><year>2000</year><volume>38</volume><fpage>I129</fpage><lpage>I141</lpage><pub-id pub-id-type="doi">10.1097/00005650-200006001-00013</pub-id><pub-id pub-id-type="pmid">10843277</pub-id></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hulscher</surname><given-names>ME</given-names></name><name><surname>Wensing</surname><given-names>M</given-names></name><name><surname>Grol</surname><given-names>RP</given-names></name><name><surname>van Der</surname><given-names>WT</given-names></name><name><surname>van Weel</surname><given-names>C</given-names></name></person-group><article-title>Interventions to improve the delivery of preventive services in primary care</article-title><source>Am J Public Health</source><year>1999</year><volume>89</volume><fpage>737</fpage><lpage>746</lpage><pub-id pub-id-type="doi">10.2105/AJPH.89.5.737</pub-id><pub-id pub-id-type="pmid">10224987</pub-id></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>HI</given-names></name><name><surname>Wagner</surname><given-names>EH</given-names></name><name><surname>Fihn</surname><given-names>SD</given-names></name><name><surname>Martin</surname><given-names>DP</given-names></name><name><surname>Horowitz</surname><given-names>CR</given-names></name><name><surname>Christensen</surname><given-names>DB</given-names></name><name><surname>Cheadle</surname><given-names>AD</given-names></name><name><surname>Diehr</surname><given-names>P</given-names></name><name><surname>Simon</surname><given-names>G</given-names></name></person-group><article-title>A randomized controlled trial of CQI teams and academic detailing: can they alter compliance with guidelines?</article-title><source>Jt Comm J Qual Improv</source><year>1998</year><volume>24</volume><fpage>130</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">9568553</pub-id></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solberg</surname><given-names>LI</given-names></name><name><surname>Fischer</surname><given-names>LR</given-names></name><name><surname>Wei</surname><given-names>F</given-names></name><name><surname>Rush</surname><given-names>WA</given-names></name><name><surname>Conboy</surname><given-names>KS</given-names></name><name><surname>Davis</surname><given-names>TF</given-names></name><name><surname>Heinrich</surname><given-names>RL</given-names></name></person-group><article-title>A CQI intervention to change the care of depression: a controlled study</article-title><source>Eff Clin Pract</source><year>2001</year><volume>4</volume><fpage>239</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">11769296</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berwick</surname><given-names>DM</given-names></name><name><surname>Nolan</surname><given-names>TW</given-names></name><name><surname>Whittington</surname><given-names>J</given-names></name></person-group><article-title>The triple aim: care, health, and cost</article-title><source>Health Aff (Millwood)</source><year>2008</year><volume>27</volume><fpage>759</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.1377/hlthaff.27.3.759</pub-id><pub-id pub-id-type="pmid">18474969</pub-id></element-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>JA</given-names></name><name><surname>Heckman</surname><given-names>TG</given-names></name><name><surname>Stevenson</surname><given-names>LY</given-names></name><name><surname>Williams</surname><given-names>PN</given-names></name><name><surname>Ertl</surname><given-names>T</given-names></name><name><surname>Hays</surname><given-names>RB</given-names></name><name><surname>Leonard</surname><given-names>NR</given-names></name><name><surname>O'Donnell</surname><given-names>L</given-names></name><name><surname>Terry</surname><given-names>MA</given-names></name><name><surname>Sogolow</surname><given-names>ED</given-names></name><name><surname>Neumann</surname><given-names>MS</given-names></name></person-group><article-title>Transfer of research-based HIV prevention interventions to community service providers: fidelity and adaptation</article-title><source>AIDS Educ Prev</source><year>2000</year><volume>12</volume><fpage>87</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">11063072</pub-id></element-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>JA</given-names></name><name><surname>Somlai</surname><given-names>AM</given-names></name><name><surname>DiFranceisco</surname><given-names>WJ</given-names></name><name><surname>Otto-Salaj</surname><given-names>LL</given-names></name><name><surname>McAuliffe</surname><given-names>TL</given-names></name><name><surname>Hackl</surname><given-names>KL</given-names></name><name><surname>Heckman</surname><given-names>TG</given-names></name><name><surname>Holtgrave</surname><given-names>DR</given-names></name><name><surname>Rompa</surname><given-names>D</given-names></name></person-group><article-title>Bridging the gap between the science and service of HIV prevention: transferring effective research-based HIV prevention interventions to community AIDS service providers 41</article-title><source>Am J Public Health</source><year>2000</year><volume>90</volume><fpage>1082</fpage><lpage>1088</lpage><pub-id pub-id-type="doi">10.2105/AJPH.90.7.1082</pub-id><pub-id pub-id-type="pmid">10897186</pub-id></element-citation></ref></ref-list></back></article>